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ABSTRACT: Described herein are two projects on the application and effects of BN/CC 
isosterism on indole-containing compounds. In the first chapter, the synthetic route to an 
unnatural boron and nitrogen-containing analogue of tryptophan (BN-tryptophan) via late-
stage functionalization of BN-indole is disclosed and its spectroscopic properties are 
reported with respect to the natural amino acid, tryptophan. The incorporation of BN-
tryptophan into proteins expressed in E. coli using selective pressure incorporation, a 
residue specific method of unnatural amino acid incorporation, is then reported and its 
reactivity and fluorescence in the proteins characterized. In the second chapter, the 
synthesis of a BN-indole-containing aromatic scaffold is reported and the cation-π binding 
ability characterized by nuclear magnetic resonance (NMR) monitored titrations is 
disclosed. The resulting chemical shifts were analyzed using a non-linear curve fitting 
procedure and the extracted association constants (Ka’s) compared with the natural indole 
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Chapter 1: Synthesis and Characterization of a Boron and Nitrogen-containing 
Tryptophan and its Incorporation into Proteins 
 
1.1. Introduction  
 
1.1.1. BN/CC Isosterism and Azaborines 
 
 The concept of BN/CC isosterism is the isoelectronic and isostructural relationship 
between a carbon-carbon (CC) bond unit and a boron-nitrogen (BN) bond unit. The effect 
this isosterism has on a molecule can be shown in one of the simplest cases, ethylene 1.1 
and its BN-analogue, aminoborane 1.2 (Figure 1.1).1 While the number of electrons and 
general geometry remains the same in each molecule, there are vast differences in their 
physical, chemical, and electronic properties. While ethylene has no dipole moment, 
aminoborane has a dipole moment of 1.844 Debye. Ethylene displays a greater bond 
dissociation energy (BDE) than aminoborane (174.1 kcal/mol versus 139.7 kcal/mol, 
respectively): the s-contribution is about the same for both, however ethylene has a greater 
π-contribution than aminoborane (65 kcal/mol versus 29.9 kcal/mol, respectively). They 
also display different reactivities. Ethylene is a stable gas under standard conditions with a 
                                               
1 Campbell, P. G.; Marwitz, A. J. V.; Liu, S.-Y. Recent Advances in Azaborine Chemistry. Angew. Chem. 















Dipole 0 D 1.844 D
BDE 174.1 kcal/mol(σ = 109.1, π = 65)
139.7 kcal/mol





Figure 1.1 BN-Isostere of Ethylene
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boiling point of –104 °C, while aminoborane is known to be unstable and polymerizes and 
oligomerizes under standard conditions. 
This concept of BN/CC isosterism can be utilized to expand the chemical space of 
arene-containing compounds that are prominent in medicinal chemistry by replacing a CC 
bond with a BN bond in benzene, indole, or other arenes.2 For example, in benzene, there 
are three possible BN-analogues that contain one boron and one nitrogen: the 1,2-, 1,3-, 
and 1,4-azaborines (Figure 1.2).1,3 The inclusion of the BN bond results in a modification 
of certain electronic characteristics,4 such as dipole moment,5 reactivity,6 and hydrogen  
                                               
2 For recent reviews, see: a) McConnell, C. R.; Liu, S.-Y. Late-Stage Functionalization of BN-Heterocycles. 
Chem. Soc. Rev. 2019, 48, 3436–3453. b) Giustra, Z. X.; Liu, S.-Y. The State of the Art in Azaborine 
Chemistry: New Synthetic Methods and Applications. J. Am. Chem. Soc. 2018, 140, 1184–1194. c) Bélanger-
Chabot, G.; Braunschweig, H.; Roy, D. K. Recent Developments in Azaborinine Chemistry. Eur. J. Inorg. 
Chem. 2017, 2017, 4353–4368. d) Morgan, M. M.; Piers, W. E. Efficient Synthetic Methods for the 
Installation of Boron-Nitrogen Bonds in Conjugated Organic Molecules. Dalt. Trans. 2016, 45, 5920–5924. 
3 Bosdet, M. J.; Piers, W. E. B-N as a C-C Substitute in Aromatic Systems. Can. J. Chem. 2009, 87, 8–29. 
4 a) McConnell, C. R.; Campbell, P. G.; Fristoe, C. R.; Memmel, P.; Zakharov, L. N.; Li, B.; Darrigan, C.; 
Chrostowska, A.; Liu, S.-Y. Synthesis and Characterization of 1,2-Azaborine-Containing Phosphine 
Ligands: A Comparative Electronic Structure Analysis. Eur. J. Inorg. Chem. 2017, 2017, 2207–2210. b) Liu, 
Z.; Ishibashi, J. S. A.; Darrigan, C.; Dargelos, A.; Chrostowska, A.; Li, B.; Vasiliu, M.; Dixon, D. A.; Liu, 
S.-Y. The Least Stable Isomer of BN Naphthalene: Toward Predictive Trends for the Optoelectronic 
Properties of BN Acenes. J. Am. Chem. Soc. 2017, 139, 6082–6085. c) Xu, S.; Mikulas, T. C.; Zakharov, L. 
N.; Dixon, D. A.; Liu, S.-Y. Boron-Substituted 1,3-Dihydro-1,3-Azaborines: Synthesis, Structure, and 
Evaluation of Aromaticity. Angew. Chem. Int. Ed. 2013, 52, 7527–7531. d) Campbell, P. G.; Abbey, E. R.; 
Neiner, D.; Grant, D. J.; Dixon, D. A.; Liu, S.-Y. Resonance Stabilization Energy of 1,2-Azaborines: A 
Quantitative Experimental Study by Reaction Calorimetry. J. Am. Chem. Soc. 2010, 132, 18048–18050. 
5 Chrostowska, A.; Xu, S.; Lamm, A. N.; Mazière, A.; Weber, C. D.; Dargelos, A.; Baylère, P.; Graciaa, A.; 
Liu, S.-Y. UV-Photoelectron Spectroscopy of 1,2- and 1,3-Azaborines: A Combined Experimental and 
Computational Electronic Structure Analysis. J. Am. Chem. Soc. 2012, 134, 10279–10285. 
6 a) Lamm, A. N.; Garner, E. B.; Dixon, D. A.; Liu, S.-Y. Nucleophilic Aromatic Substitution Reactions of 
1,2-Dihydro-1,2-Azaborine. Angew. Chem. Int. Ed. 2011, 50 , 8157–8160. b) Brown, A. N.; Li, B.; Liu, S.-
Y. Negishi Cross-Coupling Is Compatible with a Reactive B-Cl Bond: Development of a Versatile Late-
Stage Functionalization of 1,2-Azaborines and Its Application to the Synthesis of New BN Isosteres of 
Naphthalene and Indenyl. J. Am. Chem. Soc. 2015, 137, 8932–8935. c) Baggett, A. W.; Vasiliu, M.; Li, B.; 
Dixon, D. A.; Liu, S.-Y. Late-Stage Functionalization of 1,2-Dihydro-1,2-Azaborines via Regioselective 
Iridium-Catalyzed C-H Borylation: The Development of a New N,N-Bidentate Ligand Scaffold. J. Am. 
Chem. Soc. 2015, 137, 5536–5541. d) Burford, R. J.; Li, B.; Vasiliu, M.; Dixon, D. A.; Liu, S.-Y. Diels-Alder 
Reactions of 1,2-Azaborines. Angew. Chem. Int. Ed. 2015, 54, 7823–7827. e) Edel, K.; Yang, X.; Ishibashi, 
J. S. A.; Lamm, A. N.; Maichle-Mössmer, C.; Giustra, Z. X.; Liu, S.-Y.; Bettinger, H. F. The Dewar Isomer 
of 1,2-Dihydro-1,2-Azaborinines: Isolation, Fragmentation, and Energy Storage. Angew. Chem. Int. Ed. 
2018, 57, 5296–5300. f) Pan, J.; Kampf, J. W.; Ashe, A. J. Electrophilic Aromatic Substitution Reactions of 
1,2-Dihydro-1,2-Azaborines. Org. Lett. 2007, 9, 679–681. 
 3 
bonding capabilities,7 while maintaining the same number of atoms and π-electrons.  
 
1.1.2. BN/CC Isosterism and Indoles 
In addition to monocyclic arenes, BN/CC isosterism can be applied to indole. 
Indole is a bicyclic nitrogen-containing aromatic heterocycle that is ubiquitous in 
biological systems and a privileged structure in medicinal chemistry, making it an attractive 
target for isosterism studies.8 For example, it is the core of the essential amino acid, 
tryptophan 1.7, and the neurotransmitters, serotonin 1.8, melatonin 1.9, and tryptamine 
1.10 (Figure 1.3).9 These neurotransmitters are responsible for regulating animal and 
human sleep cycles, eating habits, and mood.  
 
                                               
7 Lee, H.; Fischer, M.; Shoichet, B. K.; Liu, S.-Y. Hydrogen Bonding of 1,2-Azaborines in the Binding Cavity 
of T4 Lysozyme Mutants: Structures and Thermodynamics. J. Am. Chem. Soc. 2016, 138, 12021–12024. 
8 For a review, see: Kaushik, N. K.; Kaushik, N.; Attri, P.; Kumar, N.; Kim, C. H.; Verma, A. K.; Choi, E. 
H. Biomedical Importance of Indoles. Molecules 2013, 18, 6620–6662. 
9 Fernstrom, J. D. Role of Precursor Availability in Control of Monoamine Biosynthesis in Brain. Physiol. 
Rev. 1983, 63, 484–546. b) Gingrich, J. A.; Hen, R. Dissecting the Role of the Serotonin System in 
Neuropsychiatric Disorders Using Knockout Mice. Psychopharmacology (Berl). 2001, 155, 1–10. c) Arendt, 













































Figure 1.3 Indole-containing Biologically Active Compounds
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Indole is also a major pharmacophore found in commercially available 
medications.10 Just a few examples are shown in Figure 1.4. Ondansetron 1.11, marketed 
as Zofran, was developed by GlaxoSmithKline and approved by the FDA in 1991. It is an 
antiemetic used to treat nausea and vomiting induced by chemotherapy, radiation therapy, 
and surgery.11 Sumatriptan 1.12, marketed as Imitrex, was approved by the FDA in 1992 
for the treatment of migraines and was also developed by GlaxoSmithKline.12 Fluvastatin 
1.13, marketed as Lescol, is used to treat hypercholesterolemia and to prevent 
cardiovascular disease. Lescol was developed by Novartis and approved for medical use in 
1994.13 Indomethacin 1.14 is a non-steroidal anti-inflammatory drug (NSAID) that was 
approved in 1965 by the FDA for treatment of fever, pain, and swelling.14 Osimertinib 
1.15, marketed as Tagrisso, was developed by AstraZeneca and received FDA approval in 
2017 for treatment of patients with metastatic non-small cell lung cancer that is positive 
for the epidermal growth factor receptor (EGFR) T790M mutations.15 This drug is also 
listed in the top 200 pharmaceutical drugs by retail sales in 2018.16 These examples are 
                                               
10 For recent reviews, see: a) Naim, M. J.; Alam, O.; Alam, J.; Bano, F.; Alam, P.; Shrivastava, N. Recent 
Review on Indole: A Privileged Scaffold Structure. Int. J. Pharma Sci. Res. 2016, 7, 51–62. b) Sravanthi, T. 
V.; Manju, S. L. Indoles - A Promising Scaffold for Drug Development. Eur. J. Pharm. Sci. 2016, 91, 1–10. 
c) Chadha, N.; Silakari, O. Indoles as Therapeutics of Interest in Medicinal Chemistry: Bird’s Eye View. 
Eur. J. Med. Chem. 2017, 134, 159–184. 
11 Scuderi, P.; Wetchler, B.; Sung, Y.-F.; Mingus, M.; DuPen, S.; Claybon, L.; Leslie, J.; Talke, P.; 
Apfelbaum, J.; Sharifi-Azad, S. Treatment of Postoperative Nausea and Vomiting after Outpatient Surgery 
with the 5-HT3 Antagonist Ondansetron. Anesthesiology 1993, 78, 15–20. 
12 Ferrari, et al. Treatment of Migraine Attacks with Sumatriptan. N. Engl. J. Med. 1991, 325, 316–321. 
13 Jones, P.; Kafonek, S.; Laurora, I.; Hunninghake, D. Comparative Dose Efficacy Study of Atorvastatin 
Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The 
CURVES Study). Am. J. Cardiol. 1998, 81, 582–587. 
14 Hart, F. D.; Boardman, P. L. Indomethacin a New Non-Steroid Anti-Inflammatory Agent. Br. Med. J. 
1963, 2, 965–970. 
15 Greig, S. L. Osimertinib: First Global Approval. Drugs 2016, 76, 263–273. 
16 McGrath, N. A.; Brichacek, M.; Njardarson, J. T. A Graphical Journey of Innovative Organic Architectures 
That Have Improved Our Lives. J. Chem. Educ. 2010, 87, 1348–1349. 
 5 
only a few of the many different indole containing compounds that are used to treat various 
conditions. 
 
Two BN-isosteres of indole have been developed thus far: the “external” BN-indole 
1.17 and “fused” BN-indole 1.18 (Figure 1.5). Goubeau and coworkers first introduced the 
synthesis of a substituted “external” BN-indole in 195717 and later reported the synthesis 
of the parent compound 1.17 in 1964.18 Since then, other studies have emerged on its 
synthesis, applications, and properties.19 It has mostly found application as a boryl-ligand 
in organometallic chemistry and aromatic building block in optoelectronic materials.20 
                                               
17 Ulmschneider, D.; Goubeau, J. Reaktionen des Trimethylbors. Chem. Ber. 1957, 90, 2733–2738. 
18 Goubeau, J.; Snyder, H. Darstellung von Diaminoborinen aus Diamin-monohydrochloriden und 
Natriumborhydrid. Justus Liebigs Ann. Chem. 1964, 675, 1–9. 
19 For recent reviews, see: a) Abbey, E. R.; Liu, S.-Y. BN Isosteres of Indole. Org. Biomol. Chem. 2013, 11, 
2060–2069. b) Weber, L.; Böhling, L. The Role of 2,3-Dihydro-1-H-1,3,2-Diazaboroles in Luminescent 
Molecules. Coord. Chem. Rev. 2015, 284, 236–275. 
20 For recent examples, see: a) Weber, L.; Halama, J.; Böhling, L.; Brockhinke, A.; Chrostowska, A.; 
Darrigan, C.; Dargelos, A.; Stammler, H. G.; Neumann, B. 1,3,2-Benzodiazaboroles With 1,3-
Pentafluorophenyl and Tetrafluoropyridyl Substituents As Building Blocks in Luminescent Compounds. 
Eur. J. Inorg. Chem. 2013, 24, 4268–4279. b) Weber, L.; Halama, J.; Hanke, K.; Böhling, L.; Brockhinke, 














































More recently, the N-substituted “fused” BN-indole was introduced by the Liu lab 
in 2010,21 with the parent variant 1.18 appearing a year later in 2011.22 When 1.18 is 
compared with the natural indole 1.16, it is found to have an almost identical structure and 
the same electrophilic aromatic substitution reactivity, albeit with increased nucleophilicity 
at the C3 position.23 Additionally, it was found that the N-H of “fused” BN-indole 1.18 has 
a pKa of 30 (versus 21 for indole 1.16), making it less acidic than natural indole 1.16. 
While the “external” BN-indole 1.17 has a multitude of applications as boryl-
ligands and as a component in optoelectronic materials, its hydrolytic instability has 
prevented its use in biomedical research. On the other hand, the “fused” BN-indole 1.18 
has been determined to be relatively stable in water. The physical and chemical features of 
the “fused” BN-indole could potentially be utilized in biomedical studies to alter the 
                                               
A.; Stammler, H. G.; Neumann, B.; Fox, M. A. On the Ambiguity of 1,3,2-Benzodiazaboroles as 
Donor/Acceptor Functionalities in Luminescent Molecules. Dalt. Trans. 2014, 43, 3347–3363. c) Davies, G. 
H. M.; Molander, G. A. Synthesis of Functionalized 1,3,2-Benzodiazaborole Cores Using Bench-Stable 
Components. J. Org. Chem. 2016, 81, 3771–3779. d) Kwan, E. H.; Kawai, Y. J.; Kamakura, S.; Yamashita, 
M. A Long-Tethered (P-B-P)-Pincer Ligand: Synthesis, Complexation, and Application to Catalytic 
Dehydrogenation of Alkanes. Dalt. Trans. 2016, 45, 15931–15941. e) Fu, Y.; Zhang, K.; Dmitrieva, E.; Liu, 
F.; Ma, J.; Weigand, J. J.; Popov, A. A.; Berger, R.; Pisula, W.; Liu, J.; et al. NBN-Embedded Polycyclic 
Aromatic Hydrocarbons Containing Pentagonal and Heptagonal Rings. Org. Lett. 2019, 21, 1354–1358. 
21 Abbey, E. R.; Zakharov, L. N.; Liu, S.-Y. Electrophilic Aromatic Substitution of a BN Indole. J. Am. Chem. 
Soc. 2010, 132, 16340–16342. 
22 Abbey, E. R.; Zakharov, L. N.; Liu, S.-Y. Boron in Disguise: The Parent Fused BN Indole. J. Am. Chem. 
Soc. 2011, 133, 11508–11511. 
23 Chrostowska, A.; Xu, S.; Mazière, A.; Boknevitz, K.; Li, B.; Abbey, E. R.; Dargelos, A.; Graciaa, A.; Liu, 
S.-Y. UV-Photoelectron Spectroscopy of BN Indoles: Experimental and Computational Electronic Structure 





















Figure 1.5 BN-Isosteres of Indole
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properties of known, biologically active, indole-containing compounds with minimal 
disturbance to the size of the molecule.  
1.2. Background 
 
1.2.1. 1,2-azaborines in Biological Systems 
While the chemistry of 1,2-azaborines has been expanded upon dramatically in 
recent years, little is known about the interactions of this class of arenes in the context of 
biological systems. The Liu group has led efforts into uncovering the potential for 
azaborine application to biological systems and has investigated the binding of 1,2-
azaborines in polar and non-polar binding sites in biological macromolecules.2b 
 
In the first such report in 2009, Liu and coworkers demonstrated through protein 
crystal structure analysis that 1,2-azaborines 1.4, 1.20, and 1.21 bind to the engineered 
nonpolar cavity in the L99A T4 lysozyme mutant in a similar orientation as the 
carbonaceous arene substrates 1.3 and 1.19 (Figure 1.6).24 More recently, in 2016, the 
binding of 1,2-azaborines was explored in an engineered polar cavity in the L99A/M102Q 
T4 lysozyme double mutant in order to study the hydrogen bonding capabilities of the 
azaborine N–H bond.7 Liu showed through protein crystal structure analysis of the bound 
azaborines that a hydrogen bond is present between the N-H of the azaborine and the 
                                               
24 Liu, L.; Marwitz, A. J. V.; Matthews, B. W.; Liu, S.-Y. Boron Mimetics: 1,2-Dihydro-1,2-Azaborines Bind 
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Figure 1.6 Ligand Binding Study Substrates
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carbonyl of the glutamine in the binding pocket, an interaction which is absent in the 
carbonaceous compound (Figure 1.7).  
 
The strengths of these hydrogen bonds were also measured through the use of 
isothermal titration calorimetry (ITC) and a double mutant cycle analysis. The parent 
azaborine hydrogen bond was measured to be ~1 kcal/mol while the B-ethyl-azaborine 
hydrogen bond was ~0.6 kcal/mol. In 2019, another report from the Liu group 
demonstrated the effect sterics had on the hydrogen bond strength (Figure 1.8).25 This was 
done through a similar study where the substituent on the boron was varied and the 
hydrogen bond strength measured. It was found that increasing the steric profile of the 
boron substituent decreased the strength of the hydrogen bond in a discreet fashion. 
                                               
25 Liu, Y.; Liu, S.-Y. Exploring the Strength of a Hydrogen Bond as a Function of Steric Environment Using 










Figure 1.7 Crystal Structure Representation of Benzene and Azaborine 




























Figure 1.8 Ligand Binding Substrates in Hydrogen Bond Strength Study
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In 2013, the Liu and Heider labs reported that both N-ethyl and B-ethyl-1,2-
azaborines inhibit the activity of ethylbenzene dehydrogenase (EbDH), an enzyme which 
catalyzes the hydroxylation of ethylbenzene to (S)-1-phenylethanol (Figure 1.9).26 It was 
calculated to show that a possible reason for this variation in activity between the sterically 
similar compounds is the result of the differences in stabilities of the benzylic radical and 
benzylic cation, both of which are believed to be intermediates in the oxidation of 
ethylbenzene (Table 1.1). The relative instability of the radical and cationic intermediates 
                                               
26 Knack, D. H.; Marshall, J. L.; Harlow, G. P.; Dudzik, A.; Szaleniec, M. I.; Liu, S.-Y.; Heider, J. BN/CC 
Isosteric Compounds as Enzyme Inhibitors: N- and B-Ethyl-1,2-Azaborine Inhibit Ethylbenzene 




































ethylbenzene 1.19 0 0
N-ethyl-1,2-azaborine 1.21 23.69 12.28
B-ethyl-1,2-azaborine 1.20 15.41 24.43
Table 1.1 Relative Calculated Energy Values for Radical and 
Carbocation Formation
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associated with 1,2-azaborine is believed to be the cause for their observed inhibitory 
activity against EbDH. This observed role reversal between carbonaceous arenes and 1,2-
azaborines is a direct result of BN/CC isosterism.  
1.2.2. 1,2-azaborines in Medicinal Chemistry 
Arenes are a ubiquitous pharmacophore found in many pharmaceuticals.16 The 
application of BN/CC isosterism in the field of medicinal chemistry expands the structural 
possibilities for new medications. One of the first examples of an application of BN-
containing heterocycles to medicinal chemistry was in Dewar’s work in 1964.27 Dewar 
synthesized multiple water-soluble BN-phenanthrene and BN-naphthalene isosteres and 
tested their viability as reagents in boron neutron capture therapy (BNCT) (Figure 1.10). 
While they were found to be very toxic when introduced to mice, the results indicated the 
compounds were stable in vivo.  
 
                                               
27 Dewar, M. J. S.; Hashmall, J.; Kubba, V. P. New Heteroaromatic Boron Compounds. XIX. Water-Soluble 
Derivatives of 10,9-Borazarophenanthrene and 2,1-Borazaronaphthalene as Potential Agents for Neutron 





















Figure 1.10 BN-Isosteres of Naphthalene and Phenanthrene-containing Drug-like 
Molecules Synthesized for BNCT Studies.
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It wasn’t until 2015 that another application of BN-containing arene isosteres in 
drug-like molecules was reported. Kilburn and coworkers synthesized and studied multiple 
BN-containing analogues of MP10, the compound used as a benchmark comparison of 
PDE10A inhibition, as well as other PDE10A inhibitors, with the intent to gain a better 
understanding of how the similarity between physical properties of the isosteres would 
correlate to similarities in biological interactions (Figure 1.11).28 They found that the 
activity of borazaronaphthyl-substituted analogues was diminished from the benchmark 
compound, but were nonetheless more potent than the naphthyl-substituted analogues. It 
was also shown that there is some degree of interaction with the active site, and, therefore, 
there is potential for the use of BN-naphthalenes in future medicinal chemistry studies. 
 
Later that year, Rombouts and coworkers synthesized two BN-naphthalene-
containing analogues of propranolol, a naphthalene-containing b-blocker drug, and 
compared their properties in vitro and in vivo (Figure 1.12).29 Here they found that the 
                                               
28 Vlasceanu, A.; Jessing, M.; Kilburn, J. P. BN/CC Isosterism in Borazaronaphthalenes towards 
Phosphodiesterase 10A (PDE10A) Inhibitors. Bioorg. Med. Chem. 2015, 23, 4453–4461. 
29 Rombouts, F. J. R.; Tovar, F.; Austin, N.; Tresadern, G.; Trabanco, A. A. Benzazaborinines as Novel 






















































Figure 1.11 BN-Isosteres of PDE10A inhibitors
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azaborine analogue 1.44 showed similar inhibitory potency against the b2 receptor and 
similar selectivity profile to propranolol 1.42, as well as a comparable in vitro ADME-tox 
profile. 
 
Lastly, in 2017, three BN-isosteres of known biologically active compounds were 
synthesized and tested in vivo (Figure 1.13).30 It was found that in all cases, the BN-
analogues showed similar activity to their corresponding CC-analogues as well as 
increased aqueous solubility in vitro. Of particular note, the BN-analogue 1.47b of the 
CDK2 inhibitor 1.47a showed an IC50 of 87 nM, which is significantly more potent than 
the IC50 of 320 nM for the CC-analogue. This could be attributed to the additional 
hydrogen-bonding interaction of the azaborine N–H with the binding site of CDK2. Further 
testing in a rat model demonstrated the BN-analogue has superior pharmacokinetic 
properties, as shown in Table 1.2. The greater bioavailability and lower clearance result in 
a two-fold increase in the AUCpo (area under the curve per oral administration). In 
conclusion, these desirable properties are the result of the greater solubility of the azaborine 
compound in physiological conditions. 
                                               
30 Zhao, P.; Nettleton, D. O.; Karki, R. G.; Zécri, F. J.; Liu, S.-Y. Medicinal Chemistry Profiling of 

















[a] Intravenous dose. [b] Per os dose. [c] Area under the curve (intravenous) normalized to 1 mg/kg dose. [d] 
Area under the curve (oral) normalized to 1 mg/kg dose. [e] Bioavailability. [f] Clearance rate. [g] Mean 
resonance time. 
 
1.2.3. Unnatural Analogues of Proteinogenic Amino Acids 
 Proteins in all living things are made up of 20 amino acids (with the rare exception 
of selenocysteine and pyrrolysine).31 While nature is able to function on these 20 amino 
acids, biochemists have determined a need to expand the selection of functional groups 
available in order to study proteins. Unnatural amino acids (UAAs) have been developed 
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Dopamine D3 receptor antagonist:
PPAR γ and δ antagonist:
CDK2 inhibitor:
IC50 = 1 nM
Sol. = <0.005 mM
FASSIF = 0.021 mM
IC50 = 3 nM
Sol. = 0.046 mM
FASSIF = 0.22 mM
IC50 (PPAR γ) = 1 µM
IC50 (PPAR δ) = 2 µM
Sol. = <0.004 mM
FASSIF = <0.004 mM
IC50 (PPAR γ) = 2 µM
IC50 (PPAR δ) = 1 µM
Sol. = <0.004 mM
FASSIF = 0.006 mM
IC50 = 320 nM
Sol. = <0.004 mM
FASSIF = 0.006 mM
IC50 = 87 nM
Sol. = 0.013 mM




Figure 1.13 The Effect of BN/CC Isosterism on the Biological Activity of Pharmaceutically Active Compounds
Compd i.v. [mg/kg][a] p.o. [mg/kg][b] AUCiv [nM·h][c] AUCpo [nM·h][d] F [%][e] CL [mL/min·kg][f] t1/2 [h] tmax [h] MRT [h][g] Cmax [nM]
1.47a 0.5 5.0 1261 283 22.5 39.2 10.5 0.5 0.8 692
1.47b 1.0 5.0 2092 613 29.3 23.7 11.6 1.5 2.7 746
Table 1.2 Pharmacokinetic Properties of CDK2 Inhibitors
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for this purpose. Being able to incorporate new functionalities into proteins can offer ways 
to explore and engineer the function, properties, and stability of proteins.32 
 
Researchers have found and developed many applications for UAAs. Some UAAs 
have been used to incorporate reactive handles into proteins for bioconjugation reactions 
(Figure 1.14).33 Numerous other UAAs have been developed as endogenous amino acid 
analogues to alter the fluorescent character of proteins with minimal perturbation to the 
native structure of the protein.34 Others still have been developed to probe the cellular 
                                               
32 a) Liu, C. C.; Schultz, P. G. Adding New Chemistries to the Genetic Code. Annu. Rev. Biochem. 2010, 79, 
413–444. b) Dumas, A.; Lercher, L.; Spicer, C. D.; Davis, B. G. Designing Logical Codon Reassignment-
Expanding the Chemistry in Biology. Chem. Sci. 2015, 6, 50–69. c) Neumann-Staubitz, P.; Neumann, H. The 
Use of Unnatural Amino Acids to Study and Engineer Protein Function. Curr. Opin. Struct. Biol. 2016, 38, 
119–128. 
33 a) Kim, C. H.; Axup, J. Y.; Schultz, P. G. Protein Conjugation with Genetically Encoded Unnatural Amino 
Acids. Curr. Opin. Chem. Biol. 2013, 17, 412–419. b) Lang, K.; Chin, J. W. Cellular Incorporation of 
Unnatural Amino Acids and Bioorthogonal Labeling of Proteins. Chem. Rev. 2014, 114, 4764–4806. c) 
Spicer, C. D.; Davis, B. G. Selective Chemical Protein Modification. Nat. Commun. 2014, 5, 1–14. 
34 Ross, J. B. A.; Szabo, A. G.; Hogue, C. W. V. Enhancement of Protein Spectra with Tryptophan Analogs: 





































Figure 1.14 Selection of UAAs used in Protein Studies
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mechanisms of protein synthesis.35 Some UAAs have been  developed to include elements 
not commonly found in natural amino acids, such as boron36, phosphorous37, selenium38, 
and tellurium39,38b for use as therapeutics (e.g. 1.56), fluorescent tags (e.g. 1.57), handles 






                                               
35 Ngo, J. T.; Tirrell, D. A. Noncanonical Amino Acids in the Interrogation of Cellular Protein Synthesis. 
Acc. Chem. Res. 2011, 44, 677–685. 
36 a) Diaz, D. B.; Yudin, A. K. The Versatility of Boron in Biological Target Engagement. Nat. Chem. 2017, 
9, 731–742. b) Das, B. C.; Thapa, P.; Karki, R.; Schinke, C.; Das, S.; Kambhampati, S.; Banerjee, S. K.; Van 
Veldhuizen, P.; Verma, A.; Weiss, L. M.; Evans, T. Boron Chemicals in Diagnosis and Therapeutics. Future 
Med. Chem. 2013, 5, 653–676. 
37 Arribat, M.; Rémond, E.; Clément, S.; Lee, A. Van Der; Cavelier, F. Phospholyl(Borane) Amino Acids 
and Peptides: Stereoselective Synthesis and Fluorescent Properties with Large Stokes Shift. J. Am. Chem. 
Soc. 2018, 140, 1028–1034. 
38 a) Cohen, D. T.; Zhang, C.; Fadzen, C. M.; Mijalis, A. J.; Hie, L.; Johnson, K. D.; Shriver, Z.; Plante, O.; 
Miller, S. J.; Buchwald, S. L.; Pentelute, B. L. A Chemoselective Strategy for Late-Stage Functionalization 
of Complex Small Molecules with Polypeptides and Proteins. Nat. Chem. 2019, 11, 78–85. b) 
Satheeshkumar, K.; Raju, S.; Singh, H. B.; Butcher, R. J. Reactivity of Selenocystine and Tellurocystine: 
Structure and Antioxidant Activity of the Derivatives. Chem. Eur. J. 2018, 24, 17513–17522. c) Mukai, T.; 
Sevostyanova, A.; Suzuki, T.; Fu, X.; Söll, D. A Facile Method for Producing Selenocysteine-Containing 
Proteins. Angew. Chem. Int. Ed. 2018, 57, 7215–7219. d) Dantas De Araujo, A.; Perry, S. R.; Fairlie, D. P. 
Chemically Diverse Helix-Constrained Peptides Using Selenocysteine Crosslinking. Org. Lett. 2018, 20, 
1453–1456. 
39 Budisa, N.; Karnbrock, W.; Steinbacher, S.; Humm, A.; Prade, L.; Neuefeind, T.; Moroder, L.; Huber, R. 
Bioincorporation of Telluromethionine into Proteins: A Promising New Approach for X-Ray Structure 



















Figure 1.15 Selection of UAAs used in Protein Studies
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1.2.4. Unnatural Tryptophan Analogues and Their Applications 
Tryptophan residues serve as the target of many protein 
studies. Tryptophan 1.60 (Figure 1.16) is the main source of 
intrinsic fluorescence in proteins,40 participates in various π-
system interactions,41 and accounts for about 1% of amino acids 
found in proteins.42 Tryptophan’s relative scarcity, role in protein 
stability, and utility as a spectroscopic handle mark it as a useful target for protein studies. 
As such, many tryptophan analogues have been developed and studied (Figure 1.17). 
Two of the first unnatural tryptophan analogues, 7-azatryptophan 1.60a43 and 
tryptazan 1.60b44, were incorporated into proteins in E. coli in the 1950’s. When later 
incorporated into the enzyme alkaline phosphatase, it was found that the enzyme did not 
lose its activity and the only evidence of incorporation was a change in the absorbance and 
emission spectra.45 Since then, many other tryptophan analogues with different functional 
groups have been incorporated for various purposes (Figure 1.17). Other azatryptophans 
(1.60c-d), as well as many other functional group-containing tryptophans (1.60e-h), have 
                                               
40 Callis, P. R. 1L(a) and 1L(b) Transitions of Tryptophan: Applications of Theory and Experimental 
Observations to Fluorescence of Proteins. Methods Enzymol. 1997, 278, 113–150. 
41 a) Ruan, C.; Rodgers, M. T. Cation-π Interactions: Structures and Energetics of Complexation of Na+ and 
K+ with the Aromatic Amino Acids, Phenylalanine, Tyrosine, and Tryptophan J. Am. Chem. Soc. 2004, 126, 
14600–14610. b) Dougherty, D. a. Cation-π Interactions Involving Aromatic Amino Acids J. Nutr. 2007, 
137, 1504–1508. c) Dougherty, D. A. Physical Organic Chemistry on the Brain. J. Org. Chem. 2008, 73, 
3667–3673. d) Burley, S. K.; Petsko, G. A. Aromatic-Aromatic Interaction: A Mechanism of Protein 
Structure Stabilization. Science 1985, 229, 23–28. 
42 McCaul, C. P.; Ludescher, R. D. Room Temperature Phosphorescence from Tryptophan and Halogenated 
Tryptophan Analogs in Amorphous Sucrose. Photochem. Photobiol. 1999, 70, 166–171. 
43 Pardee, A. B.; Shore, V. G.; Prestidge, L. S. Incorporation of Azatryptophan into Proteins of Bacteria and 
Bacteriophage. Biochim. Biophys. Acta 1956, 21, 406–407. 
44 Brawerman, G.; Yčas, M. Incorporation of the Amino Acid Analog Tryptazan into the Protein of 
Escherichia Coli. Arch. Biochem. Biophys. 1957, 68, 112–117. 
45 Attias, J.; Schlesinger, M. J.; Schlesinger, S. The Effect of Amino Acid Analogues on Alkaline Phosphatase 









been used to alter the spectroscopic properties.46 Fluorinated tryptophans have been used 
to suppress fluorescence (1.60i),47 alter the indole’s capability to participate in 
intermolecular forces and affect protein stability (1.60i-o),48 and for use in 19F NMR studies 
(1.60i-k).49 Tryptophans functionalized with amino groups have been used as pH sensors 
(1.60p-q)50 and, along with other analogues (1.60r-x), to alter and study the spectroscopic 
properties of fluorescent proteins.51 Sulfur and selenium containing analogues (1.60y-ab) 
have been used to both alter fluorescence and as a handle in x-ray crystallography.52 Others 
                                               
46 a) Lepthien, S.; Hoesl, M. G.; Merkel, L.; Budisa, N. Azatryptophans Endow Proteins with Intrinsic Blue 
Fluorescence. Proc. Natl. Acad. Sci. 2008, 105, 16095–16100. b) Talukder, P.; Chen, S.; Arce, P. M.; Hecht, 
S. M. Efficient Asymmetric Synthesis of Tryptophan Analogues Having Useful Photophysical Properties. 
Org. Lett. 2014, 16, 556–559. c) Talukder, P.; Chen, S.; Roy, B.; Yakovchuk, P.; Spiering, M. M.; Alam, M. 
P.; Madathil, M. M.; Bhattacharya, C.; Benkovic, S. J.; Hecht, S. M. Cyanotryptophans as Novel Fluorescent 
Probes for Studying Protein Conformational Changes and DNA-Protein Interaction. Biochemistry 2015, 54, 
7457–7469. 
47 Bronskill, P. M.; Wong, J. T. Suppression of Fluorescence of Tryptophan Residues in Proteins by 
Replacement with 4-Fluorotryptophan. Biochem. J. 1988, 249, 305–308. 
48 a) Minks, C.; Huber, R.; Moroder, L.; Budisa, N. Atomic Mutations at the Single Tryptophan Residue of 
Human Recombinant Annexin V: Effects on Structure, Stability, and Activity. Biochemistry 1999, 38, 
10649–10659. b) Zhong, W.; Gallivan, J. P.; Zhang, Y.; Li, L.; Lester, H. A.; Dougherty, D. A. From Ab 
Initio Quantum Mechanics to Molecular Neurobiology: A Cation-π Binding Site in the Nicotinic Receptor. 
Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 12088–12093. c) Tobola, F.; Lelimousin, M.; Varrot, A.; Gillon, E.; 
Darnhofer, B.; Blixt, O.; Birner-Gruenberger, R.; Imberty, A.; Wiltschi, B. Effect of Noncanonical Amino 
Acids on Protein-Carbohydrate Interactions: Structure, Dynamics, and Carbohydrate Affinity of a Lectin 
Engineered with Fluorinated Tryptophan Analogs. ACS Chem. Biol. 2018, 13, 2211–2219. 
49 Seifert, M. H. J.; Ksiazek, D.; Azim, M. K.; Smialowski, P.; Budisa, N.; Holak, T. A. Slow Exchange in 
the Chromophore of a Green Fluorescent Protein Variant. J. Am. Chem. Soc. 2002, 124, 7932–7942. 
50 Sinha, H. K.; Dogra, S. K.; Krishnamurthy, M. Excited-State and Ground-State Proton-Transfer Reactions 
in 5-Aminoindole. Bull. Chem. Soc. Jpn. 1987, 60, 4401–4407. b) Budisa, N.; Rubini, M.; Bae, J. H.; Weyher, 
E.; Wenger, W.; Golbik, R.; Huber, R.; Moroder, L. Global Replacement of Tryptophan with 
Aminotryptophans Generates Non-Invasive Protein-Based Optical PH Sensors. Angew. Chem. Int. Ed. 2002, 
41, 4066–4069. 
51 a) Bae, J. H.; Rubini, M.; Jung, G.; Wiegand, G.; Seifert, M. H. J.; Azim, M. K.; Kim, J. S.; Zumbusch, 
A.; Holak, T. A.; Moroder, L.; Huber, R.; Budisa, N. Expansion of the Genetic Code Enables Design of a 
Novel “Gold” Class of Green Fluorescent Proteins. J. Mol. Biol. 2003, 328, 1071–1081. b) Chatterjee, A.; 
Xiao, H.; Yang, P. Y.; Soundararajan, G.; Schultz, P. G. A Tryptophanyl-tRNA Synthetase/tRNA Pair for 
Unnatural Amino Acid Mutagenesis in E.Coli. Angew. Chem. Int. Ed. 2013, 52, 5106–5109. c) Kwon, I.; 
Tirrell, D. A. Site-Specific Incorporation of Tryptophan Analogues into Recombinant Proteins in Bacterial 
Cells. J. Am. Chem. Soc. 2007, 129, 10431–10437. 
52 Bae, J. H.; Alefelder, S.; Kaiser, J. T.; Friedrich, R.; Moroder, L.; Huber, R.; Budisa, N. Incorporation of 
β-Selenolo[3,2-b]Pyrrolyl-Alanine into Proteins for Phase Determination in Protein X-Ray Crystallography. 
J. Mol. Biol. 2001, 309, 925–936. b) Budisa, N.; Alefelder, S.; Bae, J. H.; Golbik, R.; Minks, C.; Huber, R.; 
Moroder, L. Proteins with β-(Thienopyrrolyl)Alanines as Alternative Chromophores and Pharmaceutically 
Active Amino Acids. Protein Sci. 2001, 10, 1281–1292. c) Budisa, N.; Pal, P. P.; Alefelder, S.; Birle, P.; 
Krywcun, T.; Rubini, M.; Wenger, W.; Bae, J. H.; Steiner, T. Probing the Role of Tryptophans in Aequorea 
Victoria Green Fluorescent Proteins with an Expanded Genetic Code. Biol. Chem. 2004, 385, 191–202. 
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(1.60t,ac-ae) have been incorporated with a reactive handle for bioconjugation reactions.53 
Lastly, various others have been successfully incorporated into proteins to study ligand 
binding and spectroscopic properties (1.60af-aj).48b 
                                               
53 a) Addy, P. S.; Erickson, S. B.; Italia, J. S.; Chatterjee, A. A Chemoselective Rapid Azo-Coupling Reaction 
(CRACR) for Unclickable Bioconjugation. J. Am. Chem. Soc. 2017, 139, 11670–11673. b) Italia, J. S.; Addy, 
P. S.; Wrobel, C. J. J.; Crawford, L. A.; Lajoie, M. J.; Zheng, Y.; Chatterjee, A. An Orthogonalized Platform 
for Genetic Code Expansion in Both Bacteria and Eukaryotes. Nat. Chem. Biol. 2017, 13, 446–450. c) Addy, 
P. S.; Italia, J. S.; Chatterjee, A. An Oxidative Bioconjugation Strategy Targeted to a Genetically Encoded 
5-Hydroxytryptophan. ChemBioChem 2018, 19, 1375–1378. 
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1.2.5. Methods of Incorporation of Unnatural Amino Acid Analogues  
 Significant efforts have gone into expanding the genetic code and incorporating 
unnatural amino acids (UAAs) into proteins and peptides.54 There are multiple ways of 
incorporating UAAs into proteins, both in vitro and in vivo, and the utility of different 
methods depends on the application. In the case of shorter peptides, in vitro methods such 
as solid-phase peptide synthesis, native chemical ligation,55 and in vitro translation56 are 
the best options. For larger proteins, these methods can result in low yields and are 
technically very challenging. They also do not solve the problem of incorporating a UAA 
into a protein within the cell. There are two main ways for incorporating proteins in vivo 
via protein translation: residue-specific methods and site-specific methods, both of which 
use the cell’s endogenous biosynthetic machinery. 
The residue-specific method utilizes the aminoacyl tRNA-synthetase (aaRS) native 
to the cell to incorporate UAAs into its proteome.57 This method takes advantage of the 
promiscuity of the native aaRS; in some cases, the aaRS can charge UAAs that are 
sterically similar to a natural amino acid (NAA). This allows for the incorporation of 
                                               
54 For recent reviews, see: a) Chin, J. W. Expanding and Reprogramming the Genetic Code. Nature 2017, 
550, 53–60. b) Young, D. D.; Schultz, P. G. Playing with the Molecules of Life. ACS Chem. Biol. 2018, 13, 
854–870. 
55 a) Conibear, A. C.; Watson, E. E.; Payne, R. J.; Becker, C. F. W. Native Chemical Ligation in Protein 
Synthesis and Semi-Synthesis. Chem. Soc. Rev. 2018, 47, 9046–9068. b) Agouridas, V.; El Mahdi, O.; 
Diemer, V.; Cargoët, M.; Monbaliu, J. C. M.; Melnyk, O. Native Chemical Ligation and Extended Methods: 
Mechanisms, Catalysis, Scope, and Limitations. Chem. Rev. 2019, 119, 7328–7443. 
56 a) Quast, R. B.; Mrusek, D.; Hoffmeister, C.; Sonnabend, A.; Kubick, S. Cotranslational Incorporation of 
Non-Standard Amino Acids Using Cell-Free Protein Synthesis. FEBS Lett. 2015, 589, 1703–1712. b) 
Gregorio, N. E.; Levine, M. Z.; Oza, J. P. A User’s Guide to Cell-Free Protein Synthesis. Methods Protoc. 
2019, 2, 24. c) Gao, W.; Cho, E.; Liu, Y.; Lu, Y. Advances and Challenges in Cell-Free Incorporation of 
Unnatural Amino Acids into Proteins. Front. Pharmacol. 2019, 10, 1–8. 
57 a) Johnson, J. A.; Lu, Y. Y.; Van Deventer, J. A.; Tirrell, D. A. Residue-Specific Incorporation of Non-
Canonical Amino Acids into Proteins: Recent Developments and Applications. Curr. Opin. Chem. Biol. 
2010, 14, 774–780. b) Ngo, J. T.; Tirrell, D. A. Noncanonical Amino Acids in the Interrogation of Cellular 
Protein Synthesis. Acc. Chem. Res. 2011, 44, 677–685. 
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unnatural analogues that are isosteric to NAAs and can compete as a substrate for protein 
expression. 
The simplest residue specific method for expressing UAA-containing proteins in 
E. coli is performed via selective pressure incorporation (SPI).58 For the SPI method to 
work, an auxotrophic cell strain that is deficient in the biosynthetic machinery needed to 
make the target NAA is necessary along with control over the growth media. The cells are 
initially grown in NAA-containing media followed by a media exchange to media 
containing the UAA and lacking NAA. Induction of a target recombinant protein 
translation is done after the media switch to reduce the amount of NAA incorporation. 
Once the UAA is added, the aaRS incorporates it into the entire proteome in the cell in the 
positions the NAA residue normally occupies. 
 This approach is considered simple because it doesn’t require the engineering of a 
tailored aaRS for the unnatural amino acid. However, despite its simplicity, it has a few 
disadvantages. The number of UAAs that can be incorporated using this method is limited 
to amino acids that are sterically similar to NAAs and are a substrate for the natural amino 
acid’s aaRS. Additionally, once the media exchange occurs and initiation of protein 
synthesis is started, the UAA is incorporated into both the over-expressed recombinant 
protein and the entire proteome of the cell, which can cause issues with cell growth. Lastly, 
there is no way to select for a specific site in the protein as it will replace all occurrences 
of the natural amino acid with the UAA. 
Other methods for residue specific incorporation have been developed for amino 
acids that cannot be incorporated via SPI using the endogenous tRNA synthetases. Mutant 
                                               
58 Budisa, N. Prolegomena to Future Experimental Efforts on Genetic Code Engineering by Expanding Its 
Amino Acid Repertoire. Angew. Chem. Int. Ed. 2004, 43, 6426–6463. 
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aminoacyl-tRNA-synthetases can be developed to direct the incorporation of UAAs that 
are not substrates for native synthetases.32 Methods that have been used to develop and 
increase the selectivity of synthetases for UAAs include synthetase active site 
engineering59, aaRS overexpression60, and mutations of editing domains.61 
While residue-specific methods target the replacement of one NAA throughout the 
proteome, the site-specific method targets one site in a target recombinant protein. UAAs 
can be incorporated in a site-specific fashion via genetic code expansion, which is 
accomplished through the use of an orthogonal aaRS/tRNA pair to insert a UAA via 
nonsense or frameshift codon suppression.62 In this technique, the active site of an 
orthogonal aaRS must be evolved to select for a UAA without cross-reactivity with the 20 
endogenous amino acids.  
In comparison with the residue-specific method, the site-specific method allows the 
researcher to insert a UAA at one target site in a protein rather than at every occurrence of 
                                               
59 For examples, see: a) Datta, D.; Wang, P.; Carrico, I. S.; Mayo, S. L.; Tirrell, D. A. A Designed 
Phenylalanyl-tRNA Synthetase Variant Allows Efficient in Vivo Incorporation of Aryl Ketone Functionality 
into Proteins. J. Am. Chem. Soc. 2002, 124, 5652–5653. b) Sharma, N.; Furter, R.; Kast, P.; Tirrell, D. A. 
Efficient Introduction of Aryl Bromide Functionality into Proteins in Vivo. FEBS Lett. 2000, 467, 37–40. 
60 For an example, see: Kiick, K. L.; Van Hest, J. C. M.; Tirrell, D. A. Expanding the Scope of Protein 
Biosynthesis by Altering the Methionyl- tRNA Synthetase Activity of a Bacterial Expression Host. Angew. 
Chem. Int. Ed. 2000, 39, 2148–2152. 
61 For examples, see: a) Döring, V.; Mootz, H. D.; Nangle, L. A.; Hendrickson, T. L.; De Crécy-Lagard, V.; 
Schimmel, P.; Marlière, P. Enlarging the Amino Acid Set of Escherichia Coli by Infiltration of the Valine 
Coding Pathway. Science. 2001, 292, 501–504. b) Tang, Y.; Tirrell, D. A. Attenuation of the Editing Activity 
of the Escherichia Coli Leucyl-tRNA Synthetase Allows Incorporation of Novel Amino Acids into Proteins 
in Vivo. Biochemistry 2002, 41, 10635–10645. c) Tang, Y.; Wang, P.; Van Deventer, J. A.; Link, A. J.; 
Tirrell, D. A. Introduction of an Aliphatic Ketone into Recombinant Proteins in a Bacterial Strain That 
Overexpresses an Editing-Impaired Leucyl-tRNA Synthetase. ChemBioChem 2009, 10, 2188–2190. 
62 a) Cropp, T. A.; Schultz, P. G. An Expanding Genetic Code. Trends Genet. 2004, 20, 625–630. b) Chin, J. 
W. Expanding and Reprogramming the Genetic Code of Cells and Animals. Annu. Rev. Biochem. 2014, 83, 
379–408. c) Wals, K.; Ovaa, H. Unnatural Amino Acid Incorporation in E. Coli: Current and Future 
Applications in the Design of Therapeutic Proteins. Front. Chem. 2014, 2, 1–12. d) Smolskaya, S.; Andreev, 
Y. A. Site-Specific Incorporation of Unnatural Amino Acids into Escherichia Coli Recombinant Protein: 
Methodology Development and Recent Achievement. Biomolecules 2019, 9, 255. e) Wang, K.; Schmied, W. 
H.; Chin, J. W. Reprogramming the Genetic Code: From Triplet to Quadruplet Codes. Angew. Chem. Int. Ed. 
2012, 51, 2288–2297. 
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a NAA. It is a much more intensive method, however, since a specialized aaRS/tRNA pair 
must be evolved for the specific UAA. It is also difficult to incorporate more than one 
UAA, however, recent efforts have made this possible.63 
1.3. BN-Tryptophan 
 
Due to the presence of tryptophan in biological studies and the gap in the current 
literature for application of the “fused” BN-indole 1.18, we decided to synthesize the BN-
analogue of tryptophan 1.61 (Figure 1.18). The addition of a BN-analogue of tryptophan 
to the UAA toolbox could offer an alternative approach to probing protein function and 
fluorescent properties while also demonstrating the utility of azaborine chemistry in a 
biological context. We believe this BN-analogue of tryptophan to be an ideal substrate for 
protein studies using SPI due to BN-indole’s isosteric relationship with indole.  
                                               
63 For examples, see: a) Neumann, H.; Wang, K.; Davis, L.; Garcia-Alai, M.; Chin, J. W. Encoding Multiple 
Unnatural Amino Acids via Evolution of a Quadruplet-Decoding Ribosome. Nature 2010, 464, 441–444. b) 
Wan, W.; Huang, Y.; Wang, Z.; Russell, W. K.; Pai, P. J.; Russell, D. H.; Liu, W. R. A Facile System for 
Genetic Incorporation of Two Different Noncanonical Amino Acids into One Protein in Escherichia Coli. 
Angew. Chem. Int. Ed. 2010, 49, 3211–3214. c) Wang, K.; Sachdeva, A.; Cox, D. J.; Wilf, N. W.; Lang, K.; 
Wallace, S.; Mehl, R. A.; Chin, J. W. Optimized Orthogonal Translation of Unnatural Amino Acids Enables 
Spontaneous Protein Double-Labelling and FRET. Nat. Chem. 2014, 6, 393–403. d) Zheng, Y.; Gilgenast, 
M. J.; Hauc, S.; Chatterjee, A. Capturing Post-Translational Modification-Triggered Protein-Protein 
Interactions Using Dual Noncanonical Amino Acid Mutagenesis. ACS Chem. Biol. 2018, 13, 1137–1141. e) 
Italia, J. S.; Addy, P. S.; Erickson, S. B.; Peeler, J. C.; Weerapana, E.; Chatterjee, A. Mutually Orthogonal 
Nonsense-Suppression Systems and Conjugation Chemistries for Precise Protein Labeling at up to Three 
Distinct Sites. J. Am. Chem. Soc. 2019, 141, 6204–6212. f) Chatterjee, A.; Sun, S. B.; Furman, J. L.; Xiao, 
H.; Schultz, P. G. A Versatile Platform for Single- and Multiple-Unnatural Amino Acid Mutagenesis in 



















Figure 1.18 BN-Isostere of Trytophan
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1.3.1. Synthesis and Chiral Resolution of BN-tryptophan  
We synthesized the TBS-protected BN-indole 1.68 through a slightly modified 
version of the previously reported method from the Liu lab (Scheme 1.1).22 In place of the 
allyltriphenyl tin,22 we started with triallyl borane 1.63, which we synthesized through a 
Grignard reaction of boron trifluoride diethyl etherate and in situ generated allyl 
magnesium chloride. The triallyl borane 1.63 was then reacted with boron trichloride to 
make allylboron dichloride in situ, followed by condensation with N-TBS-N-allyl ethylene 
diamine 1.65 (synthesized from N-allyl ethylene diamine 1.64). The resulting diallyl 
species 1.66 was then subjected to ring-closing metathesis with Grubbs First Generation 
Catalyst. A modified aromatization procedure using mesitylene and 3,3-dimethyl-1-butene 



















1) n-BuLi (1.1 equiv.)
    THF, –78 °C, 1 h
2) TBSCl (1 equiv.)
    –78 °C to RT




































With the BN-indole in hand, we used the previously reported EAS method with 
dimethyliminium chloride (Scheme 1.2).21 The EAS product 1.69 was then methylated 
with iodomethane and subsequently displaced with silyl-ketene-acetal 1.7164 at an elevated 
temperature. Subjection to aqueous acidic conditions removed the Schiff base protecting 
                                               
64 Horikawa, M.; Busch-Petersen, J.; Corey, E. J. Enantioselective Synthesis of β-Hydroxy-α-Amino Acid 










































































Figure 1.19 Crystal Structure of BN-Tryptophan Ester Triflate Salt
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group. 65 Lastly, the silyl-protecting group was removed with tetrabutylammonium fluoride 
to afford the BN-tryptophan ethyl ester 1.74. A crystal structure was also acquired for the 
triflate salt of ester 1.73 (Figure 1.19). 
In order to directly compare properties with natural tryptophan, we needed to 
resolve the enantiomers. We accomplished this via chiral recycling HPLC. With the 
enantiomers of 1.74 in hand, we performed the final deprotection of the ester through basic 
hydrolysis to afford the parent BN-tryptophan amino acid salt 1.75 (Scheme 1.3). To 
confirm the HPLC separation was effective and the hydrolysis step did not racemize the 
amino acid stereocenter, we complexed it to a chiral palladium species 1.7666  and 
determined the enantiopurity by 1H NMR. By NMR, we determined that the complexes 





                                               
65 Wartmann, T.; Lindel, T. L-Phototryptophan. European J. Org. Chem. 2013, 9, 1649–1652. 
66 Levrat, F.; Stoeckli-evans, H.; Engel, N. Enantiomeric Excess Determination of a-Amino Acids by 19F 
NMR Spectroscopy of Their N,N-Dimethyl-(2,2,2-trifluoro-1-phenylethyl)amine-C,N)Palladium 
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Scheme 1.3 Synthesis of BN-Tryptophan 1.75 and Chiral Analysis
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We determined the absorption and emission properties of the resulting amino acid 















Figure 1.20 Spectroscopic Properties of (L)-Trp vs. (L)-BN-Trp
λabs λemi Stokes Shift Φ (H2O, pH 10)
(L)-trp 1.78 279 nm 356 nm 7752 cm–1 0.25 (0.31)65
(L)-BN-trp 




















Absorbance and Fluorescence Spectra of 






absorbance maximum was found at λ = 279 nm in water,67 whereas BN-tryptophan (L)-
1.75’s absorbance maximum is bathochromically shifted to λ = 294 nm. The fluorescence 
spectrum of (L)-BN-tryptophan shows an emission maximum of λ = 356 nm while L-
tryptophan shows a maximum at λ = 394 nm.67 Consequently, (L)-BN-tryptophan shows a 
larger Stokes shift of 8633 cm–1 compared to 7752 cm–1 of (L)-tryptophan. Both display a 
similar quantum yield of ~ 0.3.67 The solvatochromic properties were explored as well and 
were consistent with previous studies (See Section 1.5.6).68 
1.3.3. Incorporation of BN-Tryptophan into Green Fluorescent Proteins 
With BN-tryptophan 1.75 in hand, we evaluated the possibility of its incorporation 
into proteins as a surrogate of L-tryptophan 1.78 using the SPI method with a tryptophan 
auxotrophic strain of E. coli.52b We demonstrated that BN-tryptophan does not inhibit cell 
growth in the presence of natural tryptophan, confirming its lack of general toxicity (Figure 
1.21, columns 2 and 4). In a defined growth medium lacking tryptophan, addition of BN-
tryptophan led to weak E. coli growth relative to a culture that did not receive any 
tryptophan analogue (Figure 1.21, column 6 vs. 5). However, addition of L-tryptophan to 
the same culture resulted in significantly higher growth. This indicates that BN-tryptophan 
is accepted as a substrate for the endogenous tryptophanyl-tRNA synthetase, but proteome-
wide replacement of L-tryptophan with BN-tryptophan is not well-tolerated by E. coli. 
 
 
                                               
67 Szabo, A. G.; Rayner, D. M. Fluorescence Decay of Tryptophan Conformers in Aqueous Solution. J. Am. 
Chem. Soc. 1980, 102, 554–563. 
68 Saif, M.; Widom, J. R.; Xu, S.; Abbey, E. R.; Liu, S.-Y.; Marcus, A. H. Electric Dipole Transition Moments 
and Solvent-Dependent Interactions of Fluorescent Boron-Nitrogen Substituted Indole Derivatives. J. Phys. 
Chem. B 2015, 119, 7985–7993. 
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Figure 1.21 E. coli Cell Viability with BN-tryptophan 1.75 
 
 To further our studies, we incorporated our UAA along with three selected 
tryptophan analogues, which are known substrates for the endogenous tryptophanyl-tRNA 
synthetase, into superfolder green fluorescent protein (sfGFP).69 In this protein, there is a 
single tryptophan residue which precedes the chromophore. Expression of the full-length 
fluorescent sfGFP is reliant on successful decoding of the TGG codon, which codes for 
tryptophan. Indeed, this is what we see; the similar levels of fluorescence normalized with 
respect to optical density supports the notion that BN-tryptophan was incorporated into the 
sfGFP (Figure 1.22, columns 2 and 3). We also see similar or improved incorporation 
efficiency of BN-trp relative to 7-aza-tryptophan 1.79, 5-F-tryptophan 1.80, and 5-Me-
tryptophan 1.81, which are established surrogates of L-tryptophan (Figure 1.22). 
                                               
69 Pédelacq, J. D.; Cabantous, S.; Tran, T.; Terwilliger, T. C.; Waldo, G. S. Engineering and Characterization 





















BN-tryptophan 1.75 as a Tryptophan Surrogate
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Figure 1.22 Fluorescence/OD600 Plot – A Comparison of Tryptophan Analogues 
  
1.3.4. Reactivity of BN-Tryptophan 
We also incorporated BN-tryptophan 1.75 into a sfGFP mutant which harbors an 
additional tryptophan codon (sfGFP-151-TGG)70 at a surface exposed site and isolated the 
protein by immobilized metal-ion chromatography using a C-terminal poly-histidine tag. 
Analysis by LC/MS shows the expected mass (Figure 1.23). To further confirm the 
presence of the BN-tryptophan 1.75 in this protein, which has essentially the same mass as 
natural tryptophan 1.78, we took advantage of its unique sensitivity to the mild oxidant 
hydrogen peroxide. sfGFP incorporating either tryptophan or BN-tryptophan was briefly 
subjected to 1 mM hydrogen peroxide, quenched by dithiothreitol (DTT), and analyzed by 
full-protein MS analysis. It was found that, as shown in Figure 1.23, the protein containing 
                                               
70 J. S. Italia, P. S. Addy, C. J. J. Wrobel, L. A.  Crawford, M. J. Lajoie, Y. Zheng, A. Chatterjee Nat. Chem. 

















































tryptophan underwent partial oxidation, which is expected. In stark contrast, the identical 
treatment led to near-complete loss of the original peak for sfGFP-BN-trp. Since these two 
otherwise identical proteins only differ by the presence of BN-tryptophan, we can conclude 
that BN-tryptophan displays different reactivity from tryptophan, a characteristic that can 
potentially be utilized in future studies. 
Figure 1.23 Reactivity of BN-Tryptophan in a Fluorescent Protein 
 
 
1.3.5. Incorporation of BN-tryptophan into Ketosteroid Isomerase 
 Since tryptophan serves as the primary source of protein fluorescence, the 
incorporation of the BN-tryptophan should result in a red shift in the excitation and 
emission spectra when compared with the wild-type protein. To probe this property, we 
incorporated BN-tryptophan 1.75 into the non-fluorescent protein, ketosteroid isomerase 
(KSI), which is a homo-dimeric protein that houses two tryptophan residues in each 
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monomer.71 As expected, the fluorescence of the BN-tryptophan-containing protein (KSI-
BN) was red-shifted with respect to the L-tryptophan-containing protein (KSI-W). The 
KSI-BN and KSI-W fluorescence maxima were found to be 372 and 342 nm, 
respectively.71 In addition, we are able to distinguish the tyrosine fluorescence peak (lmax 
= 316 nm) from the BN-trp peak, while in the L-trp case, the peaks are not resolved (Figure 
1.24).72 






                                               
71 Wang, S.-F.; Kawahara, F. S.; Talalay, P. The Mechanism of the D5-3-Ketosteroid Isomerase Reaction: 
Absorption and Fluorescence Spectra of Complexes. J. Biol. Chem. 1963, 238, 576–585. 
72 Duggan, D. E.; Udenfriend, S. The Spectrophotofluorometric Determination of Tryptophan in Plasma and 































 In summary, we synthesized a BN-analogue of the canonical amino acid, 
tryptophan, and characterized its spectroscopic properties with respect to its natural 
tryptophan counterpart. We demonstrated through selective pressure incorporation that 
BN-tryptophan can be incorporated into proteins in vivo and that three different proteins 
(sfGFP, sfGFP-151-TGG, and KSI) containing BN-tryptophan can be isolated. This work 
shows that the natural tryptophanyl-tRNA synthetase can recognize an azaborine 
containing amino acid, further solidifying the potential use of BN/CC isosterism of arenes 
in a biological context.  
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1.5. Experimental Section 
1.5.1. General Considerations 
All oxygen- and moisture-sensitive manipulations were carried out under N2 using 
either standard Schlenk techniques or a nitrogen-filled glovebox. THF, Et2O, CH2Cl2, 
toluene, and pentane were dried with a solvent purification system consisting of columns 
of molecular sieves under argon. Silica gel (230-400 mesh) was dried for 12 hours at 180 
°C under high vacuum. Flash chromatography was performed with this silica gel under an 
inert atmosphere. All other chemicals and solvents were purchased and used as received. 
NMR spectra were recorded on a Varian VNMRS 600 MHz, VNMRS 500 MHz, 
INOVA 500 MHz, or VNMRS 400 MHz spectrometer. Deuterated solvents were 
purchased from Cambridge Isotope Labs. 11B NMR spectra were externally referenced to 
BF3•Et2O (δ 0). All NMR chemical shifts are reported in ppm relative to residual solvent 
for 1H and 13C NMR.  
Infrared spectroscopy was performed on a Bruker ALPHA-Platinum FT-IR 
Spectrometer with ATR-sampling module.  
High-resolution mass spectra were collected by Marek Domin on a JEOL AccuTOF 
instrument (JEOL USA, Peabody, MA), equipped with a DART ion source (IonSense, Inc., 
Danvers, MA) in positive ion mode at the Boston College Center for Mass Spectrometry.  
UV-vis absorption spectra were collected on an Agilent Cary 100 UV-Vis 
spectrometer. Emission spectra were collected on a Photon Technology International 
spectrometer. Quantum yield (Φ) was determined using a PTI K-Sphere “Petite” 
integrating sphere.  
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Analytical HPLC spectra were recorded on an Agilent 1200 Infinity Series HPLC 
equipped with a DAD detector. Recycling HPLC was performed on a Japan Analytical Co., 
Ltd. Next Recycling Preparative HPLC with UV/vis detector.  
Specific rotations measured on a Rudolph Research Analytical Autopol IV.  
Circular dichroism spectra were recorded on an Aviv Biomedical Inc. Model 420 
Circular Dichroism Spectrometer. 
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1.5.2. Synthesis of BN-tryptophan 
Synthesis of Diallyl species 1.66: 
 
 In a glove box, to a 1L round-bottom flask (RBF) containing a stir bar was added 
triallylborane 1.63 (6.71 g, 50.0 mmol) and CH2Cl2 (300 mL). The stirred solution was 
cooled to –78 °C in a dry ice/acetone bath under an atmosphere of nitrogen, and a solution 
of borontrichloride in hexanes (1.0 M, 100 mL) was added via cannula. The reaction was 
allowed to stir for 4 h at –78 °C, and then a solution of N-allyl-N’-TBS-ethylenediamine 
1.6522 (32.5 g, 150 mmol) in CH2Cl2 (100 mL) was added dropwise via cannula at –78 °C. 
Then, triethylamine (18.5 mL, 132 mmol) was added dropwise via cannula, also at –78 
°C. After addition, the reaction mixture was allowed to slowly warm to 25 °C for 16 h. At 
the conclusion of the reaction, the solvent was removed under reduced pressure and then 
transferred to a nitrogen-filled glove box. Pentane (150 mL) was added and a white 
precipitate formed. The mixture was passed through a glass frit in a glove box with copious 
washing using pentane (~100mL). The filtrate was concentrated under reduced pressure. 
The oily crude residue was purified via vacuum distillation to afford a colorless cloudy 
liquid (21.2 g, 52.9%). Product decomposes when exposed to water and/or oxygen. Spectra 





















Synthesis of Ring-closed product 1.67: 
 
 In a glove box, a 1L RBF equipped with a magnetic stir bar was charged with a 
solution of diallyl BN2-adduct 1.66 (21.3 g, 80.7 mmol) in CH2Cl2 (500 mL). Grubbs Gen. 
1 catalyst (bis(tricyclohexylphosphine) benzylidine ruthenium(IV) chloride) (2.66 g, 3.23 
mmol) was added portion wise to the stirring solution. The reaction was stirred for 2 h 
under a nitrogen atmosphere at room temperature and was monitored by 1H NMR. At the 
conclusion of the reaction, the solvent was removed under reduced pressure. The crude 
material was purified by vacuum distillation (b.p. 63 °C, 120 mTorr) to afford the 
clear colorless liquid 1.67 (15.01 g, 86%). Product decomposes when exposed to water 
and/or oxygen. Spectra of isolated compound matched previously published records.22 
 
Synthesis of BN-Indole 1.68: 
 
 In a glove box, a 500 mL RBF containing a stir bar was charged with palladium, 
10% on carbon (2.24 g, 21.2 mmol, Acros), ring-closed product 1.67 (5 g, 21.2 mmol), 3,3-
dimethylbut-1-ene (1.96 g, 23.3 mmol, 3 mL) and mesitylene (90 mL). The reaction was 

































room temperature. The suspension was filtered through a glass frit, washed with THF, and 
solvent was removed under vacuum distillation. The crude oil was passed through a silica 
plug in the glove box with DCM as eluent. Resulting oil was fractionally distilled under 
reduced pressure (b. p. 76 °C at 300 mTorr) to isolate a clear oil, TBS-BN-indole 1.68 (2.75 
g, 11.8 mmol, 56.0% yield). Spectra of isolated compound matched previously published 
records.22 
 
Synthesis of TBS-BN-gramine 1.69: 
 
In a glove box, a 500 mL RBF equipped with a stir bar was charged with TBS-BN-
indole 1.68 (2.0 g, 8.6 mmol) and N,N'-dimethylmethylene-iminium chloride (967 mg, 
10.3 mmol) and dissolved in CH2Cl2 (100 mL). The reaction was allowed to stir for 3 
hours. Solvent was removed under reduced pressure and, in a glove box, the resulting 
yellow solids were suspended in 15 mL triethylamine and 15 mL diethyl ether and passed 
through a glass frit. After the solvents were removed under reduced pressure, the product 
was purified by silica gel chromatography under a nitrogen atmosphere with 15% 
triethylamine in diethyl ether as eluent. TBS-BN-gramine 1.69 was concentrated under 
reduced pressure to yield an opaque, light yellow oil (2.15 g, 7.43 mmol, 86.3% yield). 
1H NMR (500 MHz, CD2Cl2) δ 8.01 (d, J = 6.5 Hz, 1H), 7.57 (dd, J = 11.4, 6.5 Hz, 
1H), 6.76 (d, J = 11.5 Hz, 1H), 6.62 (s, 1H), 6.38 (t, J = 7.0 Hz, 1H), 3.52 (s, 2H), 2.22 (s, 















123.56, 123.40, 108.47, 55.08, 45.38, 26.51, 19.16, -4.13 (B-C signal not observed). 11B 
NMR (160 MHz, CD2Cl2) δ 26.5. IR (ATR) 2950, 2928, 2855, 2813, 2763, 1618, 1587, 
1499, 1426, 1347, 1310, 1173, 1162, 1014, 947, 834, 806, 781, 728, 698, 678, 429 cm-1. 
HRMS (DART+) calcd. for C15H28B1N3Si1 [M+H]+ 289.21455, found 289.21513. 
 
Synthesis of TBS-BN-gramine methiodide salt 1.70: 
 
In a glove box, to a 250 mL RBF equipped with a stir bar was added TBS-BN-
gramine 1.69 (1.70 g, 5.88 mmol) and THF (75 mL). The flask was cooled to 0 °C in an 
ice bath under a nitrogen atmosphere for 15 minutes and iodomethane (1.00 g, 7.05 mmol, 
439 µL) was added dropwise via syringe. The reaction was allowed to warm to 25 °C for 
16 hours. The solids were allowed to settle in the bottom of the flask and the supernatant 
was removed via cannula under nitrogen pressure. When most of the solvent was removed, 
the solids were resuspended in CH2Cl2 and precipitated out with THF and the supernatant 
was removed by cannula. The residual solvent was removed under reduced pressure. TBS-
BN-gramine methiodide salt 1.70 was obtained as a white, powdery solid (2.45 g, 5.68 
mmol, 96.7% yield). Product decomposes when exposed to water and/or oxygen. 
1H NMR (500 MHz, DMSO-d6) δ 8.34 (d, J = 6.7 Hz, 1H), 7.57 (dd, J = 11.5, 6.5 
Hz, 1H), 7.28 (s, 1H), 6.76 (d, J = 11.5 Hz, 1H), 6.50 (t, J = 6.6 Hz, 1H), 4.83 (s, 2H), 3.06 
(s, 9H), 0.86 (s, 9H), 0.47 (s, 6H). 13C NMR (151 MHz, dmso) δ 138.77, 130.74, 126.81, 

















MHz, DMSO-d6) δ 26.2. IR (ATR) 3000, 2950, 2928, 2854, 1605, 1578, 1500, 1471, 1428, 
1364, 1324, 1296, 1252, 1154, 1119, 999, 973, 940, 838, 807, 787, 728, 700,592,430cm–1.  
 
Synthesis of silyl-ketene-acetal 1.71: 
 
To a 1 L RBF equipped with a stir bar, diisopropyl amine (3.15 g, 31.1 mmol, 4.39 
mL) and THF (300 mL) were added and cooled to –78 °C in a dry ice/acetone bath under 
an atmosphere of nitrogen. A solution of n-butyllithium (2.5 M in hexane, 28.7 mmol, 11.5 
mL) was added dropwise via syringe and the reaction was allowed to stir for 30 min. N-
(diphenylmethylene)glycine ethyl ester 1.82 (6.40 g, 24.0 mmol) was dissolved in THF (10 
mL) and added to the reaction mixture dropwise via syringe. The resulting deep red 
solution was allowed to stir for 100 min at –78 °C, after which time a solution of tert-
butyldimethylchlorosilane (5.05 g, 33.5 mmol) in THF (30 mL) was added dropwise via 
cannula. The reaction was allowed to stir and attain room temperature for 16 hours. Solvent 
was removed under reduced pressure and the crude mixture was suspended in hexane and 
passed through a glass frit. The filtrate was concentrated in vacuo. The desired product 
1.71 was isolated as a red viscous oil (8.8 g, 96% yield). The product was used without 
further purification.  
1H NMR (500 MHz, CD2Cl2) δ 7.64 – 7.59 (m, 1H), 7.48 (ddd, J = 7.8, 6.6, 2.9 Hz, 
2H), 7.42 (dt, J = 8.5, 2.0 Hz, 2H), 7.29 (dd, J = 4.5, 2.3 Hz, 3H), 7.22 – 7.17 (m, 2H), 5.62 












    THF, –78 °C, 30 min
2) –78 °C, 100 min
3) 1.5 equiv. TBSCl
    –78 °C to RT
    96%1.82 1.71
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1H), 1.21 (t, J = 7.0 Hz, 2H), 1.05 (s, 6H), 0.89 (s, 3H), 0.31 (s, 4H), 0.09 (s, 2H). 13C NMR 
(126 MHz, CD2Cl2) δ 158.65, 155.83, 141.24, 141.07, 137.87, 137.66, 129.35, 129.30, 
129.17, 129.15, 128.85, 128.63, 128.50, 128.40, 128.18, 127.97, 101.20, 98.19, 66.05, 
64.06, 54.00, 26.10, 25.95, 18.95, 18.62, 15.86, 14.85, -3.90, -4.33. IR (ATR) 3059, 2953, 
2958, 2884, 2855, 1624, 1470, 1444, 1376, 1315, 1294, 1240, 1070, 1017, 941, 826, 782, 
695, 466 cm-1. HRMS (DART+) calcd. for C23H32N1O2Si1 382.2202, found 382.2203. 
 
Synthesis of protected BN-tryptophan 1.72: 
 
 In a glove box, a 1 L RBF equipped with a stir bar was charged with TBS-BN-
gramine methiodide salt 1.70 (2.65 g, 6.20 mmol), silylketeneacetal 1.71 (7.10 g, 18.6 
mmol), and toluene (400 mL). The reaction was brought to reflux under nitrogen and 
allowed to heat at 140 °C. After 3 hours, the reaction was cooled to room temperature and 
concentrated under reduced pressure. The product was purified by silica gel 
chromatography with a gradient of ether in pentane (starting at 10% and then 40% ether) 
in the glove box to afford an orange goo (2.23 g, 76.9 %). Rf (2:3 ether:pentane) = 0.4 
1H NMR (500 MHz, CD2Cl2) δ 7.60 – 7.55 (m, 2H), 7.51 (dd, J = 11.5, 6.5 Hz, 
1H), 7.42 – 7.25 (m, 5H), 7.15 (t, J = 7.5 Hz, 2H), 6.76 – 6.72 (m, 1H), 6.58 (s, 2H), 6.51 
(s, 1H), 6.18 (t, J = 6.5 Hz, 1H), 4.31 (ddd, J = 9.1, 4.2, 1.0 Hz, 1H), 4.19 (qdd, J = 7.1, 

























= 7.1 Hz, 3H), 0.81 (s, 9H), 0.37 (d, J = 15.3 Hz, 6H). 13C NMR (126 MHz, CD2Cl2) δ 
172.08, 171.38, 139.81, 138.40, 136.30, 130.87, 129.27, 128.76, 128.48, 127.85, 126.55, 
123.15, 121.78, 108.69, 64.51, 61.61, 29.25, 26.40, 18.99, 14.60, -4.10 (B-C signal not 
observed). 11B NMR (160 MHz, CD2Cl2) δ 25.75. IR (ATR) 3063, 2953, 2927, 2855, 1735, 
1617, 1586, 1499, 1470, 1444, 1427, 1314, 1288, 1252, 1175, 1137, 1118, 1030, 945, 834, 
806, 780, 728, 694, 428 cm-1. HRMS (DART+) calcd. for C30H39B1N3O2Si1 [M+H]+ 
512.2905, found 512.2921. 
 
Synthesis of TBS-BN-tryptophan ethyl ester 1.73: 
 
To a 250 mL RBF equipped with a stir bar was added a solution of 1.72 (1.4 g, 2.7 
mmol) in THF (50 mL) which was cooled to 0 °C under an atmosphere of nitrogen in an 
ice bath. An aqueous solution of HCl (20 mL, 1M) was added dropwise via syringe and the 
solution was stirred at 0 °C for 30 minutes. The solution was diluted with 100 mL CH2Cl2 
and washed thrice with 200 mL saturated sodium bicarbonate. The organic layer was 
separated and the aqueous layer was extracted twice more with 100 mL CH2Cl2. The 
combined organic layer was washed with brine and dried over MgSO4. The solvent was 
removed under reduced pressure. The crude reaction mixture was purified by silica gel 
column, first eluted with CH2Cl2 and then 20% Et3N in CH2Cl2, to yield 1.73 (0.867 g, 






















1H NMR (500 MHz, CD2Cl2) δ 7.81 (d, J = 6.6 Hz, 1H), 7.57 (dd, J = 11.5, 6.5 Hz, 
1H), 6.77 (d, J = 12.4 Hz, 1H), 6.60 (s, 1H), 6.41 (t, J = 6.6 Hz, 1H), 4.17 – 4.09 (m, 2H), 
3.77 (dd, J = 7.6, 5.5 Hz, 1H), 3.22 (dd, J = 15.1, 5.5 Hz, 1H), 2.97 (dd, J = 15.1, 7.7 Hz, 
1H), 1.52 (s, 2H), 1.22 (t, J = 7.1 Hz, 3H), 0.90 (s, 9H), 0.46 (s, 6H). 13C NMR (126 MHz, 
CD2Cl2) δ 175.53, 138.55, 129.55, 126.76, 122.67, 121.87, 108.88, 61.46, 31.34, 26.51, 
19.16, 14.54, -4.10 (B-C signal not observed). 11B NMR (160 MHz, CD2Cl2) δ 26.0. IR 
(ATR) 2953, 2928, 2856, 1733, 1615, 1586, 1450, 1470, 1443, 1427, 1309, 1283, 1251, 
1184, 1139, 1119, 1027, 945, 835, 820, 807, 782, 729, 699, 677, 428 cm-1. HRMS 
(DART+) calcd. for C17H31B1N3O2Si1 [M+H]+ 348.22786, found 348.22637. 
 
Synthesis of BN-tryptophan ethyl ester 1.74: 
 
 A 250 mL RBF was charged with 1.73 (473 mg, 1.36 mmol), THF (50 mL), and a 
stir bar and put under a nitrogen atmosphere. While stirring, tetrabutylammonium fluoride 
(1 M in THF, 1.36 mL) was added dropwise via syringe. After 30 minutes, the solvent was 
removed under reduced pressure. The resulting brown oil was suspended in 150 mL 
toluene. The organic layer was washed four times with 200 mL water followed by one 
wash with brine. The suspension was passed through filter paper and the solvent was 





















1H NMR (500 MHz, CD2Cl2) δ 7.81 (d, J = 6.6 Hz, 1H), 7.57 (dd, J = 11.4, 6.5 Hz, 
1H), 6.82 – 6.50 (m, 3H), 6.41 (td, J = 6.6, 1.1 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 3.76 (dd, 
J = 7.9, 5.2 Hz, 1H), 3.27 – 3.19 (m, 1H), 2.96 (dd, J = 15.1, 7.9 Hz, 1H), 1.86 (s, 2H), 
1.23 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CD2Cl2) δ 175.10, 138.12, 126.03, 118.62, 
118.15, 108.45, 61.06, 53.35, 30.71, 14.05 (B-C signal not observed). 11B NMR (160 MHz, 
CD2Cl2) δ 23.44. IR (ATR) 3360, 2978, 2933, 1725, 1620, 1584, 1497, 1447, 1372, 1347, 
1306, 1264, 1188, 1095, 1077, 1023, 857, 802, 730, 694, 586, 549, 519 cm-1. HRMS 
(DART+) calcd. for C11H17B1N3O2Si1 [M+H]+ 234.1414, found 234.1405. 
 
Synthesis of BN-tryptophan 1.75: 
 
 In a glove box, to a 20 mL vial was added a stir bar, 1.74 (284 mg, 1.22 mmol), 
sodium hydroxide (97.6 mg, 2.44 mmol), and ethanol (3.00 mL) and stirred for 2 hours. 
Most of the ethanol was removed under reduced pressure. 1 mL of ether was added to the 
solution, followed by 2 mL pentane, after which a brown and white solid precipitated. The 
solid was triturated twice in pentane and ether, solution removed by pipette in between 
triturations. BN-tryptophan 1.75 was obtained as a powdery tan solid (247 mg, 89.2%). 
1H NMR (500 MHz, DMSO-d6) δ 8.34 (s, 1H), 7.91 (d, J = 5.9 Hz, 1H), 7.42 (dd, 
J = 10.8, 6.5 Hz, 1H), 6.73 (s, 1H), 6.61 (d, J = 11.3 Hz, 1H), 6.30 (t, J = 5.5 Hz, 1H), 3.24 





















178.81, 136.84, 126.46, 120.40, 117.85, 107.47, 54.37, 32.02 (B-C signal not observed). 
11B NMR (160 MHz, DMSO-d6) δ 23.22. IR (ATR) 3445, 3370, 3350, 1561, 1495, 1467, 
1449, 1406, 1346, 1326, 1306, 1074, 1051, 927, 878, 860, 728, 692, 608, 557, 541 cm-1. 
HRMS (DART+) calcd. for C9H13B1N3O2 206.11008, found 206.11063. 
 46 
1.5.3. Chiral Resolution of BN-tryptophan Ester 
 
Enantiomers of ester 1.74 were separated by chiral recycling HPLC (Chiralpak AD-
H, 25°C, 78:19.5:2.0:0.5 Hexane:Isopropanol:Methanol:n-butylamine, 5 mL/min). The 
product was cycled through 4-6 times before collection of each peak. 
Collected fractions were analyzed by chiral analytical HPLC (Chiralpak AD-H, 25 
°C, 78:19.5:2.0:0.5 Hexane:Isopropanol: Methanol:n-butylamine, 0.5 mL/min). 































1.5.4. Determination of Enantiopurity and Absolute Configuration of BN-tryptophan 
NMR Chiral Analysis: 
 
A 4mL vial was charged with Pd-complex66 1.76 (7.7 mg, 0.011 mmol), BN-
tryptophan 1.75 (5.0 mg, 0.022 mmol), and a stir bar. DMSO-D6 (0.5 mL) was added and 
the solution was allowed to stir under nitrogen for 4 hours, after which the NMR spectra 
were collected. The NMR showed quantitative formation of 1.77. The spectra of the 
resolved compounds, (D)-1.75 and (L)-1.75 are as shown in Figure 1.28. 


































d.e. Peak 1 complex (= e.e. (D)-BN-trp 1.75) = (1.00-0.06)/(1.00+0.06)= 0.8868x100% = 
90% 
d.e. Peak 2 complex (= e.e. (L)-BN-trp 1.75) = (1.00-0.05)/(1.00+0.05)= 0.9048x100% = 
90% 
Specific Rotation:  
(D)-BN-tryptophan 1.75 [α]25D = –7.600 (c = 0.50, H2O, l = 0.5 dm) 
(L)-BN-tryptophan 1.75 [α]25D = +7.600 (c = 0.50, H2O, l = 0.5 dm) 
(D)-tryptophan 1.78 [α]25D = –3.600 (c = 0.50, H2O, l = 0.5 dm) 




A 0.1 mm quartz cuvette was used for spectroscopy measurements. Methanol was 
used as solvent and concentrations of 0.1 mg/mL were used. Step size was 0.5 nm and the 
averaging time was 6 seconds. Pure methanol was used as the blank and the CD spectra 
were corrected according to it (baseline subtraction). Spectra are an average of 3 scans. 


























1.5.5. Quantum Yield Measurement of (L)-BN-tryptophan and (L)-tryptophan 
 
A dilute solution of each (L)-BN-Trp 1.75 and (L)-Trp 1.78 was prepared in water 
in a 1 cm quartz cuvette. Each solution was diluted to have an absorbance intensity between 
0.5 and 0.7 a.u. The same solution was then used to measure the quantum yield with the 
“petite” integrating sphere. 
 
For (L)-BN-Trp 1.75: 
 
Settings: 
293:265-570 nm, excitation slit width = 3.0 nm, emission slit width: 5.0 nm 
 
Results: 
1) Abs = 0.493, Φ = 0.297 
2) Abs = 0.528, Φ = 0.288 
3) Abs = 0.643, Φ = 0.307 
4) Abs = 0.605, Φ = 0.286 
5) Abs = 0.558, Φ = 0.275 
Average: Φ = 0.291 ± 0.011 
 
For (L)-Trp 1.78: 
 
Settings: 
279:250-550 nm, excitation slit width = 3.0 nm, emission slit width: 5.0 nm 
 
Results: 
1) Abs = 0.567, Φ = 0.251 
2) Abs = 0.628, Φ = 0.248 
3) Abs = 0.577, Φ = 0.247 














1.5.6. Solvatochromism of BN-tryptophan Ester and L-tryptophan Ester 
 
All solvents were degassed through at least 3 freeze-pump-thaw cycles and 
solutions were prepared in a nitrogen filled dry box. 
A dilute solution (~1-1.4x10–4 M) of each BN-Trp ester 1.74 or (L)-Trp ester 1.83 
was prepared in the specified solvent in a 1 cm quartz cuvettes and the absorbance and 
fluorescence were measured. 
 




















BN-trp 1.74 L-trp 1.83
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1.5.7. NMR Assignment of BN-tryptophan 
 
Figure 1.31: gCOSY spectrum of BN-trp 1.75 
 
 




Figure 1.33: 1H NMR spectrum of BN-trp 1.75 with proton assignments 
 
 
Figure 1.34: 13C NMR spectrum of BN-trp 1.75 with carbon assignments 
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1.5.8. Cell Fermentation and Protein Isolation 
 
Trp-auxotrophic Escherichia coli strain was purchased from ATCC (catalog 
number 49980 [genotype WP2 uvrA]). All fermentation and expression experiments were 
performed in GMML supplemented with 200 µM glucose (minimal media) (see recipe 
below). The expression host E. coli ATCC49980 was routinely transformed with either 
plasmid: pET22b-sfGFPwt, pET22b-sfGFP151TGG (subcloned via directed mutagenesis 
from pET22b-sfGFPwt using standard cloning methods, sequence below), or pET22b-
Llac-KSI-7TGA. 
The incorporation experiments were performed using cultures grown in minimal 
media in the presence of 0.0075 mM tryptophan (the optimal limiting concentration of the 
native substrate at 30 °C) and 2 mM Ampicillin (in the transformed cell cultures). Cell 
cultures were grown to ~0.5 OD600, at which time tryptophan was depleted and the desired 
tryptophan analogue (1 or 2 mM) was added along with 1 mM IPTG. End-point optical 
densities and fluorescence were measured after incubation at 30 °C overnight. 























































































































































































































1.5.9. Oxidation Study 
 
Protein oxidation studies were performed on the L-trp and BN-trp containing 
sfGFP151TGG proteins. The isolated proteins were incubated in 1 mM H2O2 for 5 minutes 
and then quenched with 1 mM DTT (dithiolthreitol).  Samples were analyzed by LC/MS 
(Agilent Technologies, 1260 Inifinity ESI–TOF) with a water/acetonitrile gradient (95% 
water to 5% water) on a C18 column. 
The expected mass is 27620 g/mol. 
LC/MS Spectra of Oxidation Study: 







sfGFP151TGG-BN-trp: 1mM DTT 
 





















1.5.10. X-Ray Crystallographic Data for BN-tryptophan Ester 
 
Crystal Data and Structure Refinement 
 
Identification code  (C17H31BN3O2Si)+(CF3O3S)-(H2O)0.5 
Empirical formula  C18 H32 B F3 N3 O5.50 S Si 
Formula weight  506.42 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 15.3865(16) Å a= 90°. 
 b = 6.5658(7) Å b= 90.703(3)°. 
 c = 26.361(3) Å g = 90°. 
Volume 2662.9(5) Å3 
Z 4 
Density (calculated) 1.263 Mg/m3 
Absorption coefficient 0.220 mm-1 
F(000) 1068 
Crystal size 0.300 x 0.130 x 0.050 mm3 
Theta range for data collection 1.524 to 28.296°. 
Index ranges -20<=h<=20, -8<=k<=8, -35<=l<=0 
Reflections collected 12647 
Independent reflections 6615 [R(int) = 0.0426] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.6264 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6615 / 4 / 325 
Goodness-of-fit on F2 1.110 
Final R indices [I>2sigma(I)] R1 = 0.0532, wR2 = 0.1440 
R indices (all data) R1 = 0.0836, wR2 = 0.1562 
Extinction coefficient na 













































































Chapter 2: Effect of BN/CC Isosterism on the Cation-π Binding Ability of Indole 
 
 
2.1. Introduction: Noncovalent Forces Involving Arenes 
Noncovalent inter- and intramolecular forces containing arenes play a key role in 
many chemical and biological processes.1 These forces are defined as attractive, non-
covalent interactions between two species and include arene-arene,2 sulfur-π,3 anion-π,4 
and cation-π5 interactions as well as hydrogen-bonding to arenes.6 One of the more 
prominent of these interactions is the cation-π interaction (Figure 1.1).  
 
The cation-π interaction is ubiquitous in many areas of biology and chemistry, 
including molecular recognition, materials chemistry, and catalysis, amongst many others.7 
                                               
1 For reviews, see: a) Meyer, E. A.; Castellano, R. K.; Diederich, F. Interactions with Arenes Interactions 
with Aromatic Rings in Chemical and Biological Recognition Angew. Chem. Int. Ed. 2003, 42, 1210–1250. 
b) Salonen, L. M.; Ellermann, M.; Diederich, F. Aromatic Rings in Chemical and Biological Recognition: 
Energetics and Structures. Angew. Chem. Int. Ed. 2011, 50, 4808–4842. 
2 a) Hunter, C. A.; Sanders, J. K. M. The Nature of π-π Interactions. J. Am. Chem. Soc. 1990, 112, 5525–
5534. b) Martinez, C. R.; Iverson, B. L. Rethinking the Term “Pi-Stacking.” Chem. Sci. 2012, 3, 2191–2201. 
3 a) Reid, K. S. C.; Lindley, P. F.; Thornton, J. M. Sulphur-Aromatic Interactions in Proteins. FEBS Lett. 
1985, 190, 209–213. b) Viguera, A. R.; Serrano, L. Side-Chain Interactions between Sulfur-Containing 
Amino Acids and Phenylalanine in α-Helices. Biochemistry 1995, 34, 8771–8779. c) Forbes, C. R.; Sinha, 
S. K.; Ganguly, H. K.; Bai, S.; Yap, G. P. A.; Patel, S.; Zondlo, N. J. Insights into Thiol-Aromatic 
Interactions: A Stereoelectronic Basis for S-H/π Interactions. J. Am. Chem. Soc. 2017, 139, 1842–1855. 
4 a) Schottel, B. L.; Chifotides, H. T.; Dunbar, K. R. Anion-π Interactions. Chem. Soc. Rev. 2008, 37, 68–83. 
b) Frontera, A.; Gamez, P.; Mascal, M.; Mooibroek, T. J.; Reedijk, J. Putting Anion-π Interactions into 
Perspective. Angew. Chem. Int. Ed. 2011, 50, 9564–9583. c) Giese, M.; Albrecht, M.; Rissanen, K. Anion-π 
Interactions with Fluoroarenes. Chem. Rev. 2015, 115, 8867–8895. 
5 Ma, J. C.; Dougherty, D. A. The Cation-π Interaction. Chem. Rev. 1997, 97, 1303–1324. 
6 a) Levitt, M.; Perutz, M. F. Aromatic Rings Act as Hydrogen Bond Acceptors. J. Mol. Biol. 1988, 201, 
751–754. b) Steiner, T.; Koellner, G. Hydrogen Bonds with π-Acceptors in Proteins: Frequencies and Role 
in Stabilizing Local 3D Structures. J. Mol. Biol. 2001, 305, 535–557. 
7 For a review, see: Mahadevi, A. S.; Sastry, G. N. Cation−π Interaction: Its Role and Relevance in Chemistry, 
Biology, and Material Science. Chem. Rev. 2013, 113, 2100–2138. 
Figure 2.1 Representation of a cation-π interaction with benzene
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Since its discovery in the 1980’s, a lot of work has been done to analyze the characteristics 
and roles of this interaction. 
2.2. Introduction: Supramolecular Chemistry and Molecular Recognition 
The field of supramolecular chemistry is the chemistry of molecular assemblies and 
the intermolecular bonds that hold molecules together, or as Lehn defines it, “chemistry 
beyond the molecule.”8 This field began with the binding of cations to crown ethers and 
cryptands, which led to the study of even more complex hosts (Figure 2.2). The pioneers 
of this chemistry – Pedersen, Lehn, and Cram – were awarded the Nobel Prize in Chemistry 
in 1987 for their work in this area.9 
 
Molecular recognition is an important aspect of supramolecular chemistry and is 
the specific and non-covalent association between a host molecule, or receptor, and a guest 
substrate, or ligand.10 Key players in molecular recognition are the intermolecular forces 
that form attractive interactions between the associating molecules. Many biological 
                                               
8 Lehn, J.-M. Supramolecular Chemistry. Science. 1993, 260, 1762–1763. 
9 Cram, D. J. The Design of Molecular Hosts, Guests, and Their Complexes Angew. Chem. Int. Ed. 1988, 27, 
1009–1112. b) Pedersen, C. J. The Discovery of Crown Ethers (Noble Lecture). Angew. Chem. Int. Ed. 1988, 
27, 1021–1027. c) Lehn, J. Supramolecular Chemistry-Scope and Perspectives. Chem. Scr. 1988, 23, 237. 
10 Lehn, J. Perspectives in Supramolecular Chemistry - From Molecular Recognition towards Molecular 































Figure 2.2 Pioneering Work in Supramolecular Chemistry
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processes rely on molecular recognition, such as enzyme-substrate binding, binding of 
neurotransmitters to neuroreceptors, ion binding to potassium ion-channels, and protein-
protein interactions, amongst many other processes. 
2.3. Background: Cation-π Interactions 
2.3.1. The Discovery of the Cation-π Interaction: Gas Phase Studies 
The cation-π interaction was first reported by Kebarle and coworkers in 1981.11 In 
this work, they observed the binding interaction of a potassium ion (K+) with benzene in 
the gas phase and measured it to have a DH = 19.2 kcal/mol (Figure 2.3). Surprisingly, they 
found K+ bound preferentially with benzene over water: the K+-water interaction was found 
to be 17.9 kcal/mol. Since benzene has no permanent dipole as water does, this warranted 
an in-depth analysis. Through calculations, they discovered the most stable conformation 
was with the K+ ion situated over the center of the ring, which suggested it was interacting 




A few years later, Meot-Ner and Deakyne demonstrated that a more complex 
cation, ammonium (NH4+), bound to olefins and benzene derivatives.12 They measured the 
                                               
11 Sunner, J.; Nishizawa, K.; Kebarle, P. Ion-Solvent Molecule Interactions in the Gas Phase. The Potassium 
Ion and Benzene. J. Phys. Chem. 1981, 85, 1814–1820. 
12 Deakyne, C. A.; Meot-Ner, M. N. Unconventional Ionic Hydrogen Bonds. 2. NH+•••π. Complexes of 





19.2 kcal/mol 17.9 kcal/mol
Figure 2.3 Interaction of K+ with benzene and water and associated binding enthapies
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NH4+-benzene interaction as having a binding energy of DH = 19.3 kcal/mol, nearly the 
same as that of K+ and benzene (Table 2.1). It was also shown that the ammonium 
interaction decreased with fluorinated arenes, predictable due to the decreased quadrupole. 
Another publication indicated that increasing the size of the ammonium cation to 
tetramethylammonium (NMe4+) results in a decrease of binding energy to 9.4 kcal/mol 
(Table 2.1).13 
 
Since Kebarle’s work, the rest of the series of mono-cationic alkali metals have 
been measured in the gas phase (Table 2.1).  Guo and coworkers measured the Na+-benzene 
interaction to have a DH = 28.0 kcal/mol.14 In another work, Taft and coworkers measured 
the free energy of the Li+-benzene interaction, which was later used to calculate the binding 
energy, which was 38.3 kcal/mol.15,7 In a more recent work, Amicangelo and Armentrout 
                                               
13 Meot-Ner, M. N.; Deakyne, C. A. Unconventional Ionic Hydrogen Bonds. 1. CHδ+•••X. Complexes of 
Quaternary Ions with n- and π-Donors. J. Am. Chem. Soc. 1985, 107, 469–474. 
14 Guo, B. C.; Purnell, J. W.; Castleman, A. W. The Clustering Reactions of Benzene with Sodium and Lead 
Ions. Chem. Phys. Lett. 1990, 168, 155–160. 
15 Taft, R. W.; Anvia, F.; Gal, J. F.; Walsh, S.; Capon, M.; Holmes, M. C.; Hosn, K.; Oloumi, G.; Vasanwala, 
R.; Yazdani, S. Free Energies of Cation-Molecule Complex Formation and of Cation-Solvent Transfers. Pure 
Appl. Chem. 1990, 62, 17–23. 
Cation (X+) Li+ Na+ K+ Rb+ Cs+ NH4+ NMe4+
Binding Enthalpies
(kcal/mol)* 38.3 28.0 19.2 15.0 14.1 19.3 9.4
X
Table 2.1 Binding enthalpies of various cations and benzene
*Gas phase measurements
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measured both the Rb+-benzene and Cs+-benzene interactions and found them to be 15.0 
and 14.1 kcal/mol, respectively.16 
2.3.2. The Emergence of the Cation-π Interactions: Solution Phase Studies 
 
Dougherty and coworkers pioneered the work on exploring cation-π interactions in 
solution.17 They demonstrated that the binding of cationic (or neutral) guests in cyclophane 
hosts 2.1 and 2.2 in organic and aqueous media was largely due to the interaction of the 
electron-rich host with the electron-deficient guest (Figure 2.4).18 Through a series of 
                                               
16 Amicangelo, J. C.; Armentrout, P. B. Absolute Binding Energies of Alkali-Metal Cation Complexes with 
Benzene Determined by Threshold Collision-Induced Dissociation Experiments and Ab Initio Theory. J. 
Phys. Chem. A 2000, 104, 11420–11432. 
17 Dougherty, D. A. The Cation-π Interaction. Acc. Chem. Res. 2013, 46, 885–893. 
18 a) Shepodd, T. J.; Petti, M. A.; Dougherty, D. A. Tight, Oriented Binding of an Aliphatic Guest by a New 
Class of Water-Soluble Molecules with Hydrophobic Binding Sites. J. Am. Chem. Soc. 1986, 108, 6085–
6087. b) Shepodd, T. J.; Petti, M. A.; Dougherty, D. A. Molecular Recognition in Aqueous Media: Donor-
Acceptor and Ion-Dipole Interactions Produce Tight Binding for Highly Soluble Guests. J. Am. Chem. Soc. 
1988, 110, 1983–1985. c) Barrans, R. E.; Dougherty, D. A.; Petti, M. A.; Shepodd, T. J. “Hydrophobic” 
Binding of Water-Soluble Guests by High-Symmetry, Chiral Hosts. An Electron-Rich Receptor Site with a 
General Affinity for Quaternary Ammonium Compounds and Electron-Deficient π Systems. J. Am. Chem. 
Soc. 1988, 110, 6825–6840. d) Stauffer, D. A.; Dougherty, D. A. Ion-Dipole Effect as a Force for Molecular 























Host 2.1 Host 2.2
Figure 2.4 Cyclophane hosts developed by Dougherty and coworkers
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manipulations of the host and guest, they found the binding interactions were stronger for 
cationic guests and aromatic hosts (Figure 2.5). When they either replaced the guest with 
a neutral molecule or the arenes in the host with saturated cyclohexanes (Host 2.2), they 
saw a significant decrease in binding.19 
 
Schneider and coworkers were also able to identify a favorable interaction between 
cationic and aromatic species in multiple studies.20 They demonstrated strong arene-
ammonium interactions using their azacyclophane host 2.6 (Figure 2.6). In one particular 
case, they measured the binding of bicyclic guests 2.9, 2.10, and 2.11 and found that the 
binding decreased as the naphthalene became more saturated, which is consistent with a 
cation-π interaction being involved in the binding (Table 2.2).21 Even more so, when using 
anionic hosts 2.7 and 2.8, they observed a decrease in binding with the neutral guests 2.9 
and 2.12, which indicates that the cationic property of host 2.6 was important. In these 
                                               
19 Kearney, P. C.; Mizoue, L. S.; Kumpf, R. A.; Forman, J. E.; McCurdy, A.; Dougherty, D. A. Molecular 
Recognition in Aqueous Media. New Binding Studies Provide Further Insights into the Cation-π Interaction 
and Related Phenomena. J. Am. Chem. Soc. 1993, 115, 9907–9919. 
20 a) Schneider, H.-J.; Blatter, T.; Zimmermann, P. Host-Guest Complexes with Closed, Half-Open, and 
Stretched Receptors: Hydrophobic Cavity Effects and Induced Pole-Dipole Interactions. Angew. Chem. Int. 
Ed. 1990, 29, 1161–1162. b) Schneider, H.-J; Güttes, D.; Schneider, U. A Macrobicyclic Polyphenoxide as 
Receptor Analogue for Choline and Related Ammonium Compounds. Angew. Chem. Int. Ed.1986, 25, 647–
649. 
21 Schneider, H.-J; Blatter, T. Modification of Hydrophobic and Polar Interactions by Charged Groups in 
Synthetic Host-Guest Complexes. Angew. Chem. Int. Ed 1988, 27, 1163–1164. b) Schneider, H.-J.; Blatter, 
T.; Simova, S.; Theis, I. Large Binding Constant Differences between Aromatic and Aliphatic Substrates in 





–ΔG° = 6.7 kcal/mol





–ΔG° = 8.4 kcal/mol





–ΔG° = 5.9 kcal/mol
KD = 47 µM
 Figure 2.5 Binding free energies and dissociation constants for the interaction with Host 2.1 in water
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studies, Schneider was able to determine that each phenyl ring in the cyclophane hosts 
contributed ~0.5 kcal/mol in binding energy due to the cation-π interaction.22 
 
 
                                               
22 Schneider, H.-J.; Schiestel, T.; Zimmermann, P. The Incremental Approach to Noncovalent Interactions: 











2.6 X = +NMe2













Figure 2.6 Hosts and guests studied by Schneider and coworkers













Table 2.2 Binding free enthalpies (kcal/mol)
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One important factor to consider when characterizing cation-π interactions in 
solution phase studies is the magnitude of the desolvation energy of the guest.18b It is well 
known that cations are very strongly solvated in water and polar solvents and in order for 
a cation to bind in a host, it must overcome that desolvation energy to have a favorable 
interaction. In fact, in the earlier aqueous phase cation-binding studies,18a Dougherty used 
quaternary ammonium compounds that were soluble in both organic and aqueous solvents 
to better study the interaction since simple cations would be too soluble in water. 
2.3.3. Cation-π Interactions in Protein Secondary Structure 
Evidence of amino groups interacting with aromatic amino acids in biological 
systems was first reported by Burley and Petsko in 1986.23 They examined 33 protein 
crystal structures for the proximity of aromatic amino acid side chains (Phe, Tyr, and Trp) 
with amine-containing amino acid side chains (Arg, Lys, Asn, Gln, and His) and found that 
the positively charged amino groups in contact with arenes were within 6Å of the arene 
ring-center (Figure 2.7). Later, however, Thornton reported that in these amino-aromatic 
interactions, the NH proton interacting with the face of the aromatic ring (i.e. an 
electrostatic interaction of the positively polarized protons with the electron density of the 
aromatic ring) are actually rare: in most cases, the sp2 NH near an aromatic residue is 
stacked with the ring (i.e. a π-stacking interaction) and participating in hydrogen-bonding 
interactions with other amino acids (Figure 2.8).24 Despite this discovery, Burley and 
Petsko’s work alerted structural biologists to the potential for aromatics to participate in 
polar-π interactions.   
                                               
23 Burley, S. K.; Petsko, G. A. Amino-Aromatic Interactions in Proteins. FEBS Lett. 1986, 203, 139–143. 
24 Mitchell, J. B. O.; Nandi, C. L.; McDonald, I. K.; Thornton, J. M.; Price, S. L. Amino/Aromatic Interactions 




Years later in 1999, Gallivan and Dougherty revisited the topic of analyzing the 
role cation-π interactions play in protein structures.25 Using energetics-based criteria in 
their statistical analysis (as opposed to the geometry-based criteria of earlier studies),23 they 
analyzed 593 high resolution, nonhomologous protein structures. In their analysis, they 
considered only cationic and aromatic side-chains (Arg or Lys interacting with Phe, Tyr, 
or Trp) and evaluated all possible cation-π interactions for those that made a significant 
energetic contribution to the stability of the proteins. In summary, they found that there is 
1 cation-π interaction for every 77 residues of protein length in the PDB, over 500,000 
cation-π interactions were in the PDB at the time of publication, and 26% of all Trp residues 
experience a significant cation-π interaction with Arg or Lys in proteins. 
                                               
25Gallivan, J. P.; Dougherty, D. A. Cation-π Interactions in Structural Biology. Proc. Natl. Acad. Sci. U. S. 
A. 1999, 96, 9459–9464. 
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Figure 2.7 Amino acids studied in protein structure analyses
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Many studies of protein structures from the PDB have since emerged.26,27 In one 
case, Crowley reported that cation-π interactions are abundant at protein-protein 
interfaces.28 They found that about half of all protein complexes and a third of protein 
homodimers exhibited at least 1 cation-π interaction and that Arg-Tyr interactions were the 
most common. With the ever-growing PDB and similar databases, there are sure to be more 
of these studies emerging to further explore the role of cation-π interactions in structural 
biology. 
                                               
26 a) Hou, Q.; Bourgeas, R.; Pucci, F.; Rooman, M. Computational Analysis of the Amino Acid Interactions 
That Promote or Decrease Protein Solubility. Sci. Rep. 2018, 8, 1–13. b) Kumar, K.; Woo, S. M.; Siu, T.; 
Cortopassi, W. A.; Duarte, F.; Paton, R. S. Cation-π Interactions in Protein-Ligand Binding: Theory and 
Data-Mining Reveal Different Roles for Lysine and Arginine. Chem. Sci. 2018, 9, 2655–2665. c) Mbaye, M. 
N.; Hou, Q.; Basu, S.; Teheux, F.; Pucci, F.; Rooman, M. A Comprehensive Computational Study of Amino 
Acid Interactions in Membrane Proteins. Sci. Rep. 2019, 9, 1–14. 
27 For more references, see: Ma, J. C.; Dougherty, D. A. The Cation-π Interaction. Chem. Rev. 1997, 97, 
1303–1324. 
28 Crowley, P. B.; Golovin, A. Cation-π Interactions in Protein-Protein Interfaces. Proteins Struct. Funct. 






















Figure 2.8 Representative examples of geometries of amino-aromatic interactions
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With the awareness of the cation-π interaction in proteins, more efforts into 
determining its role in the protein’s overall structure and function have emerged.29 In many 
cases, simpler, model studies have been performed to elucidate how the cation-π interaction 
affects the proteins.30 For instance, short peptides and mini-proteins have been used to 
simplify the targeted portion of the protein structure.31 
In a recent example from Bonneau and Kirshenbaum, a 19-residue miniature 
protein that can be used to emulate the “R…WSXWS motif”32 found in the fibronectin 
type III (Fn3) domain containing proteins was described.33 This motif forms a cation-π 
network between an Arg and two Trp residues that stabilizes a rare class of secondary 
structure, the left-handed poly proline type-II helix (PPII), in proteins and has been 
observed in many X-Ray protein crystal structures. In this work, they were able to 
demonstrate that they could replicate the cation-π network from a larger protein in a 
relatively small mini-protein. 
2.3.4. Cation-π Interactions in Ligand Binding and Ion Channels 
While many of Dougherty’s earlier works focused on the binding of cationic 
heterocycles and bulky, hydrophobic ammoniums, some of his later reports switched focus 
to more biologically relevant molecules. In 1990, they reported the binding of acetylcholine 
(ACh), a neurotransmitter, in their cyclophane hosts (Figure 2.9).34 ACh binding sites have 
                                               
29 Mahadevi, A. S.; Sastry, G. N. Cation−π Interaction: Its Role and Relevance in Chemistry, Biology, and 
Material Science. Chem. Rev. 2013, 113, 2100–2138. 
30 Kool, E. T.; Waters, M. L. The Model Student: What Chemical Model Systems Can Teach Us about 
Biology. Nat. Chem. Biol. 2007, 3, 70–73. 
31 Baker, E. G.; Bartlett, G. J.; Porter Goff, K. L.; Woolfson, D. N. Miniprotein Design: Past, Present, and 
Prospects. Acc. Chem. Res. 2017, 50, 2085–2092. 
32 R = Arginine, W = Tryptophan, S = Serine, and X represents a variable amino acid. 
33 Craven, T. W.; Cho, M. K.; Traaseth, N. J.; Bonneau, R.; Kirshenbaum, K. A Miniature Protein Stabilized 
by a Cation-π Interaction Network. J. Am. Chem. Soc. 2016, 138, 1543–1550. 
34 Dougherty, D. A.; Stauffer, D. A. Acetylcholine Binding by a Synthetic Receptor: Implications for 
Biological Recognition. Science 1990, 250, 1558–1560. 
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been shown to contain multiple aromatic amino acid residues. For instance, the molecular 
structure of ACh esterase (AChE) - a natural ACh binding site that plays a crucial role in 
cholinergic synapses and terminating synaptic transmission by hydrolyzing ACh to choline 
and acetate - contains 14 aromatic amino acid residues that make up a large portion of the 
ACh-binding site and a ~20 Å cleft that leads from the surface of the enzyme to the active 
site (known as the “aromatic gorge”).35 
 
The nicotinic ACh receptor (nAChR) is another important and well-studied 
neuroreceptor that binds ACh and has been a source of evidence of cation-π binding 
interactions in ACh binding sites (Figure 2.10).36 The nAChR is a ligand-gated ion channel 
in which ACh binds to the receptor, triggering a conformational change that opens an ion 
channel that is within the protein. Interest in this particular protein lies in that nicotine, a 
stimulant and cholinomimetic drug present in tobacco, is an agonist for this receptor and 
that nAChR plays an important role in nicotine addiction.37 Many studies have been done 
to elucidate the role of cation-π interactions in the binding of ACh or nicotine.7 
                                               
35 Sussman, J. L.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Atomic Structure of 
Acetylcholinesterase from Torpedo Californica: A Prototypic Acetylcholine-Binding Protein. Science 1991, 
253, 872–879. 
36 Schmitt, J. D.; Sharples, C. G. V.; Caldwell, W. S. Molecular Recognition in Nicotinic Acetylcholine 
Receptors: The Importance of π-Cation Interactions. J. Med. Chem. 1999, 42, 3066–3074. 
37 Tapper, A. R.; McKinney, S. L.; Nashmi, R.; Schwarz, J.; Deshpande, P.; Labarca, C.; Whiteaker, P.; 
Marks, M. J.; Collins, A. C.; Lester, H. A. Nicotine Activation of a4* Receptors: Sufficient for Reward, 









Figure 2.9 Structure of Acetylcholine
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Aromatic amino acids populate many cation binding sites, in fact, a common motif 
seen in cationic binding sites is known as the “aromatic box”.17 One of the best examples 
of this is seen in the ACh binding proteins (AChBP).38 The AChBP showed that the agonist 
binding site contains three tyrosine and two tryptophan residues that form an aromatic box. 
A similar motif has been found in multiple other proteins, including some completely 
unrelated proteins, which demonstrates the overarching importance of cation-π interactions 
in ligand recognition.39,1b,7 
                                               
38 Brejc, K.; Van Dijk, W. J.; Klaassen, R. V.; Schuurmans, M.; Van Der Oost, J.; Smit, A. B.; Sixma, T. K. 
Crystal Structure of an ACh-Binding Protein Reveals the Ligand-Binding Domain of Nicotinic Receptors. 
Nature 2001, 411, 269–276. 
39a) Haga, K.; Kruse, A. C.; Asada, H.; Yurugi-Kobayashi, T.; Shiroishi, M.; Zhang, C.; Weis, W. I.; Okada, 
T.; Kobilka, B. K.; Haga, T.; et al. Structure of the Human M2 Muscarinic Acetylcholine Receptor Bound to 
























Cation-π interactions also play a major role in ion selectivity in ion channels. 
Cloning and sequencing of the Shaker voltage-dependent K+ ion channel revealed the 
structure of these channels, which led to various studies on how the pore region selects for 
certain cations.40 In 1992, Heginbotham and MacKinnon suggested that cation-π 
interactions may be responsible for ion selectivity in their studies on the mechanism in 
which tetraethylammonium (TEA), a K+ channel inhibitor, interacts with the binding site.41 
This proposal was further supported by Dougherty and coworkers’ report in 1993.42 
Through computational methods, they determined the selectivity of ion 
(K+>Rb+>>Na+>Li+) binding to benzene in an aqueous environment to mimic cation 
selectivity seen in voltage-gated potassium channels. Many other studies have since been 
performed to establish the role of cation-π interactions in ion channels.43 
2.3.5. Cation-π Interactions in Biological Systems Involving Tryptophan 
Despite its rarity in proteins, studies have shown that tryptophan, with its electron-
rich indole side-chain, is one of the main contributors to cation-p interactions in biological 
                                               
Banner, D. W.; Schlatter, D.; Benz, J.; Stihle, M.; Diederich, F. Quantification of Cation-π Interactions in 
Protein-Ligand Complexes: Crystal-Structure Analysis of Factor Xa Bound to a Quaternary Ammonium Ion 
Ligand. Angew. Chemie - Int. Ed. 2005, 44, 4400–4404. 
40 a) Miller, C. Annus Mirabilis of Potassium Channels. Science. 1991, 252, 1092–1096. b) Doyle, D. A.; 
Cabral, J. M.; Pfuetzner, R. A.; Kuo, A.; Gulbis, J. M.; Cohen, S. L.; Chait, B. T.; MacKinnon, R. The 
Structure of the Potassium Channel: Molecular Basis of K+ Conduction and Selectivity. Science 1998, 280, 
69–77. 
41 Heginbotham, L.; MacKinnon, R. The Aromatic Binding Site for Tetraethylammonium Ion on Potassium 
Channels. Neuron 1992, 8, 483–491. 
42 Kumpf, R. A.; Dougherty, D. A. A Mechanism for Ion Selectivity in Potassium Channels: Computational 
Studies of Cation-π Interactions. Science 1993, 261, 1708–1710. 
43 a) Pless, S. A.; Galpin, J. D.; Niciforovic, A. P.; Ahern, C. A. Contributions of Counter-Charge in a 
Potassium Channel Voltage-Sensor Domain. Nat. Chem. Biol. 2011, 7, 617–623. b) Xu, Y.; Shin, H. G.; 
Szép, S.; Lu, Z. Physical Determinants of Strong Voltage Sensitivity of K + Channel Block. Nat. Struct. Mol. 
Biol. 2009, 16, 1252–1258. c) Fernandez, D.; Ghanta, A.; Kauffman, G. W.; Sanguinetti, M. C. 
Physicochemical Features of the HERG Channel Drug Binding Site. J. Biol. Chem. 2004, 279, 10120–10127. 
d) González, W.; Riedelsberger, J.; Morales-Navarro, S. E.; Caballero, J.; Alzate-Morales, J. H.; González-
Nilo, F. D.; Dreyer, I. The pH Sensor of the Plant K +-Uptake Channel KAT1 Is Built from a Sensory Cloud 
Rather than from Single Key Amino Acids. Biochem. J. 2012, 442, 57–63. e) Ahern, C. A.; Eastwood, A. L.; 
Lester, H. A.; Dougherty, D. A.; Horn, R. A Cation-π Interaction between Extracellular TEA and an Aromatic 
Residue in Potassium Channels. J. Gen. Physiol. 2006, 128, 649–657. 
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settings.44 Of the three aromatic amino acids that participate in cation-π interactions, 
tryptophan is the strongest π-donor. Due to tryptophan’s cation-π binding ability, it plays 
a crucial role in the stability of proteins. For instance, it has been shown to stabilize the 
secondary structure of b-hairpin peptides.45 
 
Tryptophan is also prevalent in neurobiology and is found in neurotransmitter 
receptors, as shown in the early work of Dougherty, in which 
he reports his studies on tryptophan’s role in the 
acetylcholine receptor in nAChR.34 Dougherty and 
coworkers have demonstrated the importance of the 
tryptophan residue in the nAChR through the use of in vivo 
nonsense suppression method to incorporate tryptophan 
                                               
44 a) Dougherty, D. A. Cation-P Interactions Involving Aromatic Amino Acids. J. Nutr. 2007, 137, 1504–
1508. b) Xiu, X.; Puskar, N. L.; Shanata, J. A. P.; Lester, H. A.; Dougherty, D. A. Nicotine Binding to Brain 
Receptors Requires a Strong Cation- Interaction. Nature 2009, 458, 534–537. 
45 a) Riemen, A. J.; Waters, M. L. Design of Highly Stabilized Β-Hairpin Peptides through Cation - π 
Interactions of Lysine and N-Methyllysine with an Aromatic Pocket. Biochemistry 2009, 48, 1525–1531. b) 
Santiveri, C. M.; Jiménez, M. A. Tryptophan Residues: Scarce in Proteins but Strong Stabilizers of β-Hairpin 
Peptides. Biopolymers 2010, 94, 779–790. c) Mahalakshmi, R. Aromatic Interactions in β-Hairpin Scaffold 



































Figure 2.12 Binding Model 
of Acetylcholine to Trp
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analogues with varying electronic characteristics (Figure 2.11).46 This study helped them 
identify one Trp residue in the binding site that is responsible for the binding of ACh and 
other quaternary ammonium ligands (Figure 2.10, Trp149). (A model of ACh binding to 
trp can be seen in Figure 2.12). Progressive fluorination led to an increase in EC50 of 
acetylcholine and a decrease in the calculated binding energy, which indicates that 
tryptophan plays a key role in binding of ACh (Table 2.3).  
 
A subsequent study explored the role of Trp in the binding of various ammonium 
agonists to the nAChR and serotonergic (5-HT3A) receptors (Figure 2.13).47 Here they saw 
the same trend in decrease in binding strength with progressive fluorination. The energetic 
                                               
46 Zhong, W.; Gallivan, J. P.; Zhang, Y.; Li, L.; Lester, H. A.; Dougherty, D. A. From Ab Initio Quantum 
Mechanics to Molecular Neurobiology: A Cation-π Binding Site in the Nicotinic Receptor. Proc. Natl. Acad. 
Sci. U. S. A. 1998, 95, 12088–12093. 
47 Beene, D. L.; Brandt, G. S.; Zhong, W.; Zacharias, N. M.; Lester, H. A.; Dougherty, D. A. Cation-π 
Interactions in Ligand Recognition by Serotonergic (5-HT3A) and Nicotinic Acetylcholine Receptors: The 























Table 2.3 Binding Energies and EC50 Values of ACh Binding
* Calculated negative binding energies of a generic Na+ to 
appropriate arene.
 100 
contribution of the cation-π interaction was estimated to be ~4 kcal/mol in the binding of 
serotonin to 5-HT3AR and ~2 kcal/mol for ACh binding to nAChR. 
 
2.3.6. The Fundamental Nature of the Cation-π Interaction 
 The cation-π interaction is defined as the interaction of a cationic species with an 
electron π-system and involves the interaction of a cation with a permanent quadrupole 
moment (Figure 2.14).48 Since the discovery of the cation-π interaction and its importance 
in biological processes, theoretical and experimental studies have been done to determine 
its fundamental nature.1b Even so, there is still much debate on the full nature of the cation-
π interactions. However, in many cases, a simplified model can be useful for predicting 
interactions between various cations and π-systems.  
                                               
48 Dougherty. D. A. Cation-π Interactions in Chemistry and Biology: A New View of Benzene, Phe, Tyr and 
Trp. Science 1996, 271, 163–169. 



































The electrostatic model, first proposed by Kebarle, is the generally accepted 
defining nature of the cation-π interaction.49 The electrostatic component of the interaction 
was proposed to be the main contributing factor to the interaction partly due to the trends 
observed in gas phase studies. The comparison of simple alkali metal cations binding to 
benzene shows a classic electrostatic trend in binding strengths: Li+>Na+>K+>Rb+. Smaller 
cations are expected to bind stronger in an electrostatic sequence, whereas if polarizability 
or dispersion forces were prominent, an opposite trend is expected. 
Calculations have further shown that one of the main contributing factors to the 
cation-π interaction is the electrostatic component. Early work by Dougherty demonstrated 
the importance of the electrostatic component in the cation-π interaction through 
computational studies with the model system of binding Na+ to various aromatic molecules 
that emphasized the electrostatic component of the π-system (Figure 2.15).50 He showed 
that electrostatics can be used as a qualitative guide to cation-π interactions, and later, 
published a more extensive study on using electrostatic potential maps on biologically 
relevant aromatics to predict cation-π interactions.51  
                                               
49 Kebarle, P. Ion Thermochemistry and Solvation from Gas Phase Ion Equilibria. Annu. Rev. Phys. Chem. 
1977, 28, 445–476. 
50 Mecozzi, S.; West, A. P.; Dougherty, D. A. Cation-π Interactions in Simple Aromatics: Electrostatics 
Provide a Predictive Tool. J. Am. Chem. Soc. 1996, 118, 2307–2308. 
51 Mecozzi, S.; West, A. P.; Dougherty, D. A. Cation-π Interactions in Aromatics of Biological and Medicinal 











2.4. Background: BN/CC Isosterism and Electronic Structure 
 
2.4.1. Electronic Properties of BN-Indole 
 
The incorporation of a BN-bond in place of a CC-double bond in indole results in 
an isoelectronic and isostructural analogue of indole (Figure 2.16). As described in the first 
chapter, while the BN-indole maintains the same steric profile as its carbonaceous 
counterpart, the electronic and chemical properties of the indole are altered.52 
                                               
52 Abbey, E. R.; Liu, S. Y. BN Isosteres of Indole. Org. Biomol. Chem. 2013, 11, 2060–2069. 
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Figure 2.16 BN/CC Isosterism of Indole
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In 2010, the Liu group reported that the BN-indole demonstrates the same 
selectivity in electrophilic aromatic substitution reactions but is more nucleophilic.53 In 
competition studies, it was shown that the BN-indole reacts preferentially over indole in a 
Mannich reaction with dimethyliminium chloride to form the gramine derivative (Scheme 
2.1a). In a later study, it was also shown that the BN-indole did not undergo a second 
addition to the indole nitrogen, while in the indole case, a second addition does occur 
(Scheme 2.1b). 54 This report also showed that the BN-indole displays a higher HOMO-
                                               
53 Abbey, E. R.; Zakharov, L. N.; Liu, S. Y. Electrophilic Aromatic Substitution of a BN Indole. J. Am. Chem. 
Soc. 2010, 132, 16340–16342. 
54 Chrostowska, A.; Xu, S.; Mazière, A.; Boknevitz, K.; Li, B.; Abbey, E. R.; Dargelos, A.; Graciaa, A.; Liu, 
S. Y. UV-Photoelectron Spectroscopy of BN Indoles: Experimental and Computational Electronic Structure 




























































2.1            :             1
Scheme 2.1 Mannich Reactions of Indole and BN-indole
a) Competition reaction between indole and BN-indole
b) Selectivity of the Mannich reaction of BN-indole and indole
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orbital coefficient at the C2 and C3 positions when compared with the indole, which 
corroborates the reactivity difference between the two indoles (Figure 2.17). 
 
Chrostowska and Liu also reported a detailed study on the electronic structure of 
BN-indole through a combination of UV-photoelectron spectroscopy experiments and 
computational studies.54 This study shows that the BN-indole has a smaller ground state 
dipole moment, is less aromatic (based on NICS values), and has a similar HOMO level 
energy compared to natural indole (Table 2.3). 
 
In 2011, the Liu group performed an NMR bracketing study to determine the pKa 
of the nitrogen-H.55 They demonstrated that the pKa was significantly increased to ~30, 
whereas the natural indole has a pKa of 20.95. It was also shown that the BN-indole has 
red-shifted absorbance and emission spectra as well as a greater Stokes shift (Table 2.3). 
These changes in properties are considered a direct result of BN/CC isosterism. 
 
 
                                               
55 Abbey, E. R.; Zakharov, L. N.; Liu, S. Y. Boron in Disguise: The Parent Fused BN Indole. J. Am. Chem. 









Figure 2.17 HOMO of Indoles with Selected π-orbital Coefficients
pKa λabs λemi Dipole NICS (0) NICS (1) HOMO (eV)
Indole 2.38 20.95 268 nm 315 nm 2.177 D –10.4, –12.9* –11.7, –10.9* 7.9
BN-indole 2.39 30 293 nm 360 nm 1.512 D –6.5, –11.0* –7.8, –8.1* 8.05
*five-membered ring
Table 2.3 Selected Properties of Indole and BN-indole.
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2.4.2. Computational Studies on Non-covalent Interactions with BN-heterocycles 
 
 
 While the vast majority of studies have focused on benzene and other more 
common heterocycles, very few studies have been performed on BN-containing 
heterocycles. In a study from 2005, the cation-π interactions of borazine 2.38 and its B-
trifluoroborazine derivative 2.39 were explored computationally (Figure 2.18).56 The 
results showed that the cation-π interaction with alkali cations was still favorable with 
borazine and its B-trifluoroborazine derivative (Table 2.4 vs. Table 2.1). They also found 
that the borazine compounds “puckered” in the presence of a cation with the three nitrogens 
being drawn closer and the borons pushed away. In the case of benzene, no such change in 
conformation is seen. They hypothesized the reasoning for this change is the attraction and 
repulsion between partial negative charge over the nitrogens and partial positive charge 
over the borons with the cation as well as the lower degree of aromaticity in borazine. 
                                               
56 Miao, R.; Yang, G.; Zhao, C.; Hong, J.; Zhu, L. Theoretical Study of Borazine and Its Fluoroderivatives: 























Table 2.4 Interaction Energies (kcal/mol)
Li+ Na+ K+
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 Another computational work observed the same trend of borazine binding to 
various cations.57 Within that study, it was found that the addition of electron-donating 
groups (EDG) to borazine increases the cation-π interaction and electron-withdrawing 
groups (EWG) decreases it, much like with benzene (Figure 2.19). Table 2.5 shows the 
calculated binding complexations of the explored arenes. 
 
 
                                               
57 Bania, K. K.; Guha, A. K.; Bhattacharyya, P. K.; Sinha, S. Effect of Substituent and Solvent on Cation-π 


































































 More recently, in 2018, the Korona group studied the interaction of Na+ and Mg2+ 
with the three regioisomers of azaborine, 1,2-, 1,3-, and 1,4-azaborine, as well as mono-
substituted variants through calculations (Figure 2.20).58 It was found that the location of 
the cation bound to the ring was dependent on the location of the boron and nitrogen and 
the type of cation. In the case of benzene, 
the cation is always located above the 
center of the ring. This work, and another 
report from Korona,59 suggest that more 
than the π-contribution needs to be considered, such as s-polarization and induction 
energy, with regards to the azaborine compounds in order to accurately predict the 
interaction. In the case of benzene, usually the electrostatic π-contribution is sufficient. 
 
2.5. Indole-scaffold Studies 
In Chapter 1, the incorporation of a BN-analogue of tryptophan into recombinant 
proteins was detailed. With this new ability to incorporate a BN-containing amino acid into 
proteins in our toolbox, learning about BN-indole’s p-donating abilities could help us 
strategically apply our BN-tryptophan to other proteins. In order to probe the cation-p 
strength, we synthesized a BN-indole-containing scaffold 2.48 and determined the 
association constant by NMR, and compared the results with the natural indole scaffold 
2.49 (Figure 2.21). This system was previously developed and explored by Hof and 
                                               
58 Yourdkhani, S.; Chojecki, M.; Korona, T. Interaction of Non-Polarizable Cations with Azaborine Isomers 
and Their Mono-Substituted Derivatives: Position, Induction, and Non-Classical Effects Matter. 
ChemPhysChem 2018, 19, 3092–3106. 
59 Yourdkhani, S.; Chojecki, M.; Korona, T. Substituent Effects in the So-Called Cation⋯π Interaction of 
Benzene and Its Boron-Nitrogen Doped Analogues: Overlooked Role of σ-Skeleton. Phys. Chem. Chem. 














Figure 2.20. Azaborine Isomers
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coworkers in order to study the cation-p binding ability of indole in aqueous and organic 
media.60  
 
2.5.1. Synthesis of BN-indole Scaffold 
In the Liu lab, we synthesized the CC-indole scaffold 2.49 as previously reported 
by Hof.60 The synthesis of the BN-indole scaffold 2.48 was accomplished by adapting the 
method to synthesize the CC-indole scaffold 2.49 to the BN-system. Deprotonation of the 
BN-indole 2.39 with potassium hydride in dimethylformamide followed by addition of the 
1,3,5-tribromomethylbenzene electrophile 2.50 led to the formation of the BN-scaffold 
2.48 (Scheme 2.2). 
 
                                               
60 Whiting, A. L.; Neufeld, N. M.; Hof, F. A Tryptophan-Analog Host Whose Interactions with Ammonium 






























(4.2 equiv.) (1 equiv.)
KH
RT, DMF, 6 h
22%
2.482.39 2.50
Scheme 2.2 Synthesis of BN-scaffold 2.48
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2.5.2. NMR Titrations 
With the scaffolds in hand, the chemical shifts for scaffolds 2.48 and 2.49 were first 
unambiguously assigned via 2D NMR techniques (NOESY, HSQC, HMBC, COSY) prior 
to the titration experiments (see Sections 2.6.3 and 2.6.4). In order to compare the BN- and 
CC-scaffolds directly, we chose to look at the chemical shift changes associated with the 
C5 proton of the indole for the following reasons: 1) It is known that cations will bind 
preferentially to the six-membered ring of the indole,25,61 thus a proton within the six-
membered ring is appropriate, 2) the C5 proton signal is sharp and the chemical shift is 
easily assignable for both scaffolds,62 and 3) the electrostatic potential (ESP) maps reveal 
a consistent negatively charged area located near the C5 and C6 positions for both scaffolds 
(Figure 2.22). 
 
                                               
61 a) Brocchieri, L.; Karlin, S. Geometry of Interplanar Residue Contacts in Protein Structures. Proc. Natl. 
Acad. Sci. U. S. A. 1994, 91, 9297–9301. b) Aoki, K.; Murayama, K.; Nishiyama, H. Cation-π Interaction 
between the Trimethylammonium Moiety and the Aromatic Ring within Indole-3-Acetic Acid Choline Ester, 
a Model Compound for Molecular Recognition between Acetylcholine and Its Esterase: An X-Ray Study. J. 
Chem. Soc. Chem. Commun. 1995, 764, 2221–2222. 
62 The C5 and C6 proton chemicals shifts for the CC scaffold 2.49 overlap. However, the chemical shift 










Figure 2.22 Electrostatic Potential Surfaces of CC- and BN-indole
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We them performed NMR titrations to determine the association constants for the 
binding of a lithium and sodium cation to the scaffolds (Figures 2.23 and 2.24). In both 
cases, a 0.9-1 mM solution of scaffold was made in acetonitrile-D3 and titrated with a 2.38-
2.56 M solution of lithium iodide or a 771-820 mM solution of sodium iodide in 
acetonitrile-D3. The scaffold concentration was kept consistent between the scaffold 
solution and the salt solutions in order to eliminate any dilution effects that may arise. The 
resulting change in chemical shifts was fitted using the online resource provided by 
Thordarson,63 and the association constants (Ka) were extracted. 
Figure 2.23. Representative NMR spectra 
of LiI to BN-scaffold 2.48 titration 
 
Figure 2.24. Representative NMR spectra 
of LiI to CC-scaffold 2.49 titration 
 
We found BN-scaffold 2.48 gave a slightly lower Ka than the CC-scaffold 2.49 
(Table 2.6). Binding with lithium iodide gave a slightly lower association constant for the 
BN-scaffold 2.48 with a Ka of 0.055 ± 0.003 M–1 compared to a Ka of 0.060 ± 0.004 M–1 
for the CC-scaffold 2.49. As expected from a solution phase cation-π binding system, the 
Ka for the binding of Na+ (vs. Li+) to BN-scaffold 2.48 was higher at 0.20 ± 0.01 M–1 and 
at 0.23 ± 0.04 M–1 for the CC-scaffold 2.49. Overall, these results show that the 
                                               
63a) See for binding model: Thordarson, P. Determining Association Constants from Titration Experiments 
in Supramolecular Chemistry. Chem. Soc. Rev. 2011, 40, 1305–1323. b) supramolecular.org. 
http://supramolecular.org (Accessed: 12/21/2019) 
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incorporation of the BN-bond into the indole motif results in a slightly lower cation-π 
binding ability. 
 
2.5.3. Computational Studies 
 We also performed, in collaboration with Clovis Darrigan, a computational analysis 
of the gas-phase cation-p binding energy of Li+, Na+, and K+ to the aromatic CC and BN-
indole rings (Table 2.7). Three trends can be interpreted from the results. First, in all cases, 
the cation binds more strongly to the indole-π6-system than the indole-π5-system, and the 
interaction of both CC-indole-π5 and BN-indole-π5 systems with K+ is unfavorable and 
unable to be measured. Second, the cations bind to CC-indole stronger than BN-indole by 
2.5 kcal/mol for Li+, 1.45 kcal/mol for Na+, and 1.32 kcal/mol for K+, with respect to 
indole-π6, and 1.20 kcal/mol for Li+ and 1.45 kcal/mol for Na+, with respect to indole-π5. 
Lastly, as is expected in the gas phase, the smaller Li+ binds the strongest and the larger K+ 
the weakest. The ESP maps (Figure 2.22) were also calculated and show that in both arenes 
there is a significant negative charge over the six-membered ring in both indoles, which is 
consistent with predicted stronger cation binding affinity for the p6 ring system over the p5 




0.060 ± 0.004 M–1
0.055 ± 0.003 M–1
0.23 ± 0.04 M–1
0.20 ± 0.01 M–1
Table 2.6 Association Constants of Lithium and Sodium Cation to Indole-Scaffolds
1 Measured with C5 1H NMR shifts









2.48: (X–Y) = (B–N)





 The NMR and computational results agree in some respects and disagree in others. 
In terms of the comparison between the BN- and CC-substitution, the smaller association 
constant seen for the BN-scaffold is corroborated by the calculated energy values. It is also 
important to note that the calculated energy values are gas phase values and therefore do 
not consider desolvation energies. Therefore, while the trend of the cation series in cation-
π binding is opposite in the NMR versus the computational data, this is actually expected, 
as previously reported in Dougherty’s early work.42 
There also appears to be a correlation between the location of the negative charge 
in the ESP maps and the magnitude of the chemical shift change Dd upon cation binding 
in the NMR titrations: for CC-indole 2.38, the C2 position appears to be less electron rich 
according to the ESP map. This results in a small observed Dd upon Li+ or Na+ binding 
(Figure 2.24)). For BN-indole 2.39, the C2, C3, and C4 positions are relatively electron 
deficient, and consequently, the observed Dd for these positions are smaller than the Dd for 
the C5, C6, and C7 positions (Figure 2.23). It appears that the additional nitrogen atom in 
BN-indole 2.39 exerts its electronegative influence on the C3 and C4 positions giving rise 
ΔERig(Li+) ΔERig(Na+) ΔERig(K+)
CC-Indole 2.38-π6 -48.3 -31.5 -23.0
BN-Indole 2.39-π6 -45.8 -30.1 -21.7
CC-Indole 2.38-π5 -42.9 -28.1 ––––
BN-Indole 2.39-π5 -41.7 -26.8 ––––
Energy values in kcal/mol. ∆ERig corresponds to the binding 
energy taking into account the basis set superposition error 
(BSSE).
Table 2.7 Calculated Binding Energies of Indole and BN-indole with Alkali Cations
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to a more non-uniform and position-dependent Dd as a function of the titrated cation 
concentration relative to the CC indole 2.38. Furthermore, we can see that the C7 position 
in BN indole 2.29 appears to be the most electron rich position, most likely due to the 
inductively donating adjacent boron, and as a consequence, the C7 proton experiences the 
largest Dd upon titration with cation (Figure 2.23). 
2.5.5. Conclusions 
 In conclusion, our results demonstrate that the incorporation of a B–N bond in 
indole has a slight effect on the arene’s ability to bind simple cations as shown in our 
titration experiments. These results are corroborated through computations that indicate 
that there is slight difference in the cation-binding energy of the CC and BN-indoles. This 
knowledge could be used to help further predict the outcome of incorporating a BN-
heterocycle in future chemical and biological applications.  
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2.6. Experimental Section 
2.6.1. General Considerations 
All oxygen- and moisture-sensitive manipulations were carried out under N2 using 
either standard Schlenk techniques or a nitrogen-filled glovebox. DMF, Et2O, CH2Cl2, and 
pentane were dried with a solvent purification system consisting of columns of molecular 
sieves under argon. Silica gel (230-400 mesh) was dried for 12 hours at 180 °C under high 
vacuum. Preparatory thin layer chromatography plates (TLC) were dried in an oven at 140 
°C for 16 hours. Flash chromatography and TLC were performed with this silica gel under 
an inert atmosphere. All other chemicals and solvents were purchased and used as received. 
NMR spectra were recorded on a Varian VNMRS 600 MHz or VNMRS 500 MHz 
spectrometer. Deuterated solvents were purchased from Cambridge Isotope Labs. 11B 
NMR spectra were externally referenced to BF3•Et2O (δ 0). All NMR chemical shifts are 
reported in ppm relative to residual solvent for 1H and 13C NMR.  
Infrared spectroscopy was performed on a Bruker ALPHA-Platinum FT-IR 
Spectrometer with ATR-sampling module.  
High-resolution mass spectra were collected by Marek Domin on a JEOL AccuTOF 
instrument (JEOL USA, Peabody, MA), equipped with a DART ion source (IonSense, Inc., 
Danvers, MA) in positive ion mode at the Boston College Center for Mass Spectrometry.  
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2.6.2. Synthesis of BN-indole Scaffold 
BN-indole 2.39 was prepared according to Abbey, et al.55 
Synthesis of 2.48: 
 
 
 In a glove box, an oven-dried 20 mL vial was charged with stir bar and BN-indole 
2.39 (130 mg, 1.10 mmol, 4.2 equiv.) and dissolved in dimethylformamide (DMF) (6 
mL). Potassium hydride (46.3 mg, 1.15 mmol, 4.4 equiv.) was added. The reaction mixture 
was allowed to stir at room temperature. After 2 hours, 1,3,5-tris(bromomethyl)benzene 
2.50 (94 mg, 0.26 mmol, 1.0 equiv.) was dissolved in DMF (0.5 mL), added dropwise to 
the stirring reaction, and was allowed to continue stirring for 4 hours. The reaction was 
then quenched with water (15 mL) and transferred to a separatory funnel. Ethyl acetate (60 
mL) was added and the layers separated. The organic layer was washed three times with 
water and once with brine, dried over MgSO4, filtered, and volatiles removed under 
reduced pressure. The brown oil was then purified via preparatory thin layer 
chromatography in a glove box with 20% diethyl ether in pentane as eluent. The desired 
spot was scraped off with a spatula, the product was desorbed with dichloromethane 
(DCM), and concentrated in vacuo. Product was isolated as a tan solid (27 mg, 0.058 mmol, 
















(4.2 equiv.) (1 equiv.)
KH




6.5 Hz, 3H), 7.02 (s, 3H), 6.89 (d, J = 2.2 Hz, 3H), 6.64 – 6.56 (m, 6H), 6.33 (t, J = 6.5 Hz, 
3H), 4.89 (s, 6H). 13C NMR (126 MHz, CD2Cl2) δ 141.65, 138.84, 129.52, 125.74, 123.64, 
116.51, 112.12, 108.94, 51.01.11B NMR (160 MHz, CD2Cl2) δ 25.3. IR (ATR) 2921.0, 
2852.5, 1600.6, 1549.5, 1493.7, 1454.1, 1436.3, 1348.6, 1313.9, 1194.3, 1161.2, 1141.7, 
1072.1, 1033.1, 983.3, 954.0, 865.9, 855.4, 815.8, 743.3, 726.6, 696.3, 674.4, 634.0, 613.7, 
584.3, 535.6, 499.4, 485.6, 436.4 cm-1. HRMS (DART+) calcd. for C27H28B3N6 [M+H]+ 
469.26491, found 469.26515. 
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2.6.5. NMR Titration Spectra and Peak Data 
 
LiI to CC-Scaffold 2.49: Titration 1 
 
[LiI] Stock (M) [CC-scaffold] (M)    
2.535  0.00103     
[LiI] 






(𝚫𝛿)| C3 (𝛿) 
|C3 
(𝚫𝛿)| 
0.000 7.556142 0.000000 6.943974 0.000000 6.440985 0.000000 
0.055 7.547886 0.008256 6.934208 0.009766 6.432748 0.008237 
0.158 7.534667 0.021475 6.923134 0.020840 6.419299 0.021686 
0.253 7.522397 0.033745 6.910922 0.033052 6.406954 0.034031 
0.461 7.497326 0.058815 6.896899 0.047075 6.381709 0.059276 
0.634 7.476051 0.080090 6.882412 0.061562 6.360276 0.080709 
0.780 7.458818 0.097323     6.343124 0.097861 
1.014 7.431852 0.124289 6.866386 0.077588 6.316016 0.124969 
1.193 7.411545 0.144597 6.853966 0.090008 6.295491 0.145494 
1.334 7.395900 0.160242 6.840152 0.103822 6.279426 0.161559 
1.584 7.369182 0.186960 6.819534 0.124440 6.253326 0.187659 
1.748 7.351856 0.204286 6.801469 0.142505 6.236054 0.204931 
2.535 7.274398 0.281743 6.746772 0.197202 6.159424 0.281561 
All shifts in ppm      
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[LiI] Stock (M) [CC-scaffold] (M)    
2.376  0.00103     
[LiI] 






(𝚫𝛿)| C3 (𝛿) 
|C3 
(𝚫𝛿)| 
0.000 7.556464 0.000000 7.038319 0.000000 6.441086 0.000000 
0.052 7.548728 0.007737 7.028194 0.010125 6.433422 0.007663 
0.148 7.535648 0.020816 7.017718 0.020601 6.420261 0.020825 
0.238 7.524238 0.032227 7.006057 0.032262 6.408660 0.032425 
0.432 7.499775 0.056690 6.981338 0.056981 6.384192 0.056894 
0.594 7.480709 0.075756 6.961984 0.076335 6.365077 0.076009 
0.731 7.464211 0.092254     6.348458 0.092628 
0.950 7.438634 0.117830 6.918862 0.119457 6.322794 0.118292 
1.118 7.419255 0.137210 6.898980 0.139339 6.303443 0.137643 
1.250 7.404322 0.152142 6.883628 0.154691 6.288512 0.152574 
1.485 7.378322 0.178142 6.856837 0.181482 6.262724 0.178362 
1.638 7.361243 0.195221 6.838594 0.199726 6.245561 0.195525 
All shifts in ppm      
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LiI to CC-Scaffold 2.49: Titration 3 
 
[LiI] Stock (M) [CC-scaffold] (M)    
2.442  0.00095     
[LiI] 






(𝚫𝛿)| C3 (𝛿) 
|C3 
(𝚫𝛿)| 
0.000 7.556931 0.000000 7.038703 0.000000 6.441480 0.000000 
0.053 7.548255 0.008676 7.030824 0.007880 6.433359 0.008121 
0.153 7.534815 0.022116 7.016986 0.021718 6.419298 0.022183 
0.244 7.522400 0.034531 7.004672 0.034032 6.407261 0.034219 
0.444 7.497547 0.059384 6.979218 0.059486 6.381963 0.059517 
0.611 7.477432 0.079499 6.958611 0.080093 6.361669 0.079811 
0.751 7.460906 0.096025     6.345062 0.096418 
0.977 7.434208 0.122723 6.914436 0.124268 6.318441 0.123039 
1.149 7.414483 0.142448 6.893834 0.144870 6.298421 0.143059 
1.285 7.398725 0.158206 6.878109 0.160594 6.283099 0.158381 
1.526 7.373027 0.183904 6.850923 0.187781 6.257157 0.184324 
1.684 7.352312 0.204619 6.829298 0.209405 6.236508 0.204972 




LiI to BN-Scaffold 2.48: Titration 1 
 
[LiI] Stock (M) [BN-scaffold] (M)    
2.549  0.00098     
[LiI] 
(M) C3 (
𝛿) |C3 (𝚫𝛿)| C7 (𝛿) 
|C7 
(𝚫𝛿)| C5 (𝛿) 
|C5 
(𝚫𝛿)| 
0.000 6.928642 0.000000 6.530723 0.000000 6.299486 0.000000 
0.055 6.926693 0.001949 6.523508 0.007216 6.293090 0.006396 
0.159 6.922358 0.006284 6.509570 0.021153 6.280696 0.018790 
0.255 6.917896 0.010745 6.496644 0.034079 6.269310 0.030176 
0.463 6.908647 0.019994 6.470143 0.060580 6.246143 0.053344 
0.637 6.900363 0.028279 6.447980 0.082743 6.226615 0.072871 
0.784 6.893497 0.035144 6.429991 0.100732 6.210758 0.088728 
1.019 6.881950 0.046692 6.401046 0.129677 6.185245 0.114241 
1.199 6.872681 0.055961 6.379191 0.151532 6.166140 0.133347 
1.341 6.865398 0.063243 6.362450 0.168274 6.151403 0.148084 
1.593 6.852864 0.075778 6.334027 0.196697 6.126004 0.173483 
1.758 6.843961 0.084681 6.314939 0.215785 6.109045 0.190441 
All shifts in ppm      
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LiI to BN-Scaffold 2.48: Titration 2 
 
[LiI] Stock (M) [BN-scaffold] (M)    
2.464  0.00098     
[LiI] 
(M) C3 (
𝛿) |C3 (𝚫𝛿)| C7 (𝛿) 
|C7 
(𝚫𝛿)| C5 (𝛿) 
|C5 
(𝚫𝛿)| 
0.000 6.928988 0.000000 6.530936 0.000000 6.299460 0.000000 
0.054 6.926669 0.002318 6.523183 0.007753 6.293003 0.006457 
0.154 6.922330 0.006658 6.508887 0.022049 6.280389 0.019071 
0.246 6.918376 0.010611 6.497099 0.033836 6.269656 0.029804 
0.448 6.908774 0.020213 6.470081 0.060854 6.246120 0.053340 
0.616 6.900862 0.028125 6.448732 0.082204 6.227136 0.072324 
0.758 6.894088 0.034900 6.430975 0.099961 6.211585 0.087875 
0.986 6.882481 0.046506 6.402263 0.128673 6.186309 0.113151 
1.160 6.873692 0.055296 6.381329 0.149607 6.167752 0.131708 
1.297 6.866636 0.062352 6.364942 0.165994 6.153355 0.146105 
1.540 6.853801 0.075186 6.335646 0.195289 6.127476 0.171984 
1.699 6.845524 0.083464 6.317741 0.213195 6.111231 0.188229 
All shifts in ppm      
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LiI to BN-Scaffold 2.48: Titration 3 
 
[LiI] Stock (M) [BN-scaffold] (M)    
2.501  0.00098     
[LiI] 
(M) C3 (𝛿) 
|C3 
(𝚫𝛿)| C7 (𝛿) 
|C7 
(𝚫𝛿)| C5 (𝛿) 
|C5 
(𝚫𝛿)| 
0.000 6.929349 0.000000 6.531114 0.000000 6.300157 0.000000 
0.054 6.926989 0.002360 6.523922 0.007193 6.293655 0.006502 
0.156 6.922320 0.007029 6.509818 0.021297 6.281220 0.018937 
0.250 6.918140 0.011209 6.497273 0.033842 6.270007 0.030150 
0.455 6.909009 0.020340 6.471090 0.060025 6.246890 0.053267 
0.625 6.901063 0.028287 6.449816 0.081298 6.228266 0.071891 
0.770 6.893967 0.035382 6.431481 0.099634 6.212164 0.087993 
1.001 6.882761 0.046589 6.403234 0.127880 6.187138 0.113019 
1.177 6.873821 0.055529 6.381881 0.149233 6.168488 0.131669 
1.316 6.866949 0.062400 6.365585 0.165530 6.153898 0.146259 
1.563 6.854445 0.074904 6.337271 0.193844 6.128878 0.171279 
1.725 6.845804 0.083545 6.318689 0.212425 6.111986 0.188171 
All shifts in ppm      
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NaI to CC-Scaffold 2.49: Titration 1 
 
[NaI] Stock (M) [CC-scaffold] (M)    
0.817  0.00103     
[NaI] 






(𝚫𝛿)| C3 (𝛿) 
|C3 
(𝚫𝛿)| 
0.000 7.556692 0.000000 7.038616 0.000000 6.440964 0.000000 
0.018 7.553741 0.002951 7.035894 0.002722 6.438516 0.002448 
0.043 7.549074 0.007618 7.030844 0.007772 6.433243 0.007722 
0.082 7.544948 0.011744 7.027023 0.011593 6.428958 0.012007 
0.149 7.536619 0.020072 7.018515 0.020101 6.421224 0.019740 
0.204 7.529563 0.027128 7.011399 0.027217 6.414054 0.026911 
0.251 7.524023 0.032669 7.005725 0.032891 6.408427 0.032537 
0.327 7.514919 0.041773 6.996480 0.042136 6.399242 0.041722 
0.384 7.508311 0.048381 6.989549 0.049067 6.392515 0.048450 
0.430 7.502718 0.053974 6.984248 0.054368 6.387302 0.053662 
0.511 7.494282 0.062410 6.975378 0.063238 6.378562 0.062402 
0.563 7.488658 0.068033 6.969324 0.069292 6.372789 0.068176 
0.817 7.464801 0.091891 6.945099 0.093517 6.348925 0.092040 
All shifts in ppm      
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NaI to CC-Scaffold 2.49: Titration 2 
 
[NaI] Stock (M) [CC-scaffold] (M)    
0.820  0.00102     
[NaI] 






(𝚫𝛿)| C3 (𝛿) 
|C3 
(𝚫𝛿)| 
0.000 7.556859 0.000000 7.038562 0.000000 6.440914 0.000000 
0.018 7.553879 0.002981 7.035912 0.002650 6.438439 0.002475 
0.051 7.548905 0.007954 7.030920 0.007642 6.433603 0.007311 
0.082 7.544802 0.012057 7.026828 0.011734 6.429425 0.011489 
0.149 7.536514 0.020345 7.018295 0.020267 6.421003 0.019910 
0.205 7.529892 0.026967 7.011651 0.026911 6.414357 0.026556 
0.252 7.524127 0.032733 7.005728 0.032834 6.408410 0.032503 
0.328 7.515195 0.041664 6.996671 0.041891 6.399460 0.041453 
0.386 7.508499 0.048360 6.989874 0.048688 6.392797 0.048116 
0.432 7.503507 0.053352 6.984711 0.053851 6.387715 0.053198 
0.513 7.494745 0.062115 6.975685 0.062877 6.378984 0.061930 
0.566 7.488909 0.067950 6.969712 0.068850 6.373021 0.067892 
0.820 7.462144 0.094716 6.943104 0.095459 6.346838 0.094075 
All shifts in ppm      
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NaI to CC-Scaffold 2.49: Titration 3 
 
[NaI] Stock (M) [CC-scaffold] (M)    
0.792  0.00102     
[NaI] 






(𝚫𝛿)| C3 (𝛿) 
|C3 
(𝚫𝛿)| 
0.000 7.555884 0.000000 7.038075 0.000000 6.440790 0.000000 
0.017 7.554467 0.001417 7.035628 0.002447 6.439416 0.001373 
0.050 7.548906 0.006978 7.031333 0.006742 6.433832 0.006958 
0.079 7.546129 0.009755 7.027799 0.010276 6.430105 0.010685 
0.144 7.537226 0.018658 7.019058 0.019017 6.421726 0.019064 
0.198 7.530396 0.025488 7.012196 0.025879 6.414865 0.025925 
0.244 7.524996 0.030887 7.006717 0.031358 6.409299 0.031491 
0.317 7.516154 0.039729 6.997659 0.040416 6.400440 0.040350 
0.373 7.509789 0.046094 6.991104 0.046971 6.393986 0.046804 
0.417 7.504616 0.051268 6.985786 0.052289 6.388802 0.051988 
0.495 7.495922 0.059962 6.976908 0.061167 6.380030 0.060760 
0.546 7.490539 0.065345 6.971452 0.066623 6.374644 0.066146 
0.792 7.464801 0.091083 6.944919 0.093156 6.348929 0.091861 
All shifts in ppm      
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NaI to BN-Scaffold 2.48: Titration 1 
 
[NaI] Stock (M) [BN-scaffold] (M)    
0.771  0.00098     
[NaI] 
(M) C3 (𝛿) 
|C3 
(𝚫𝛿)| C7 (𝛿) 
|C7 
(𝚫𝛿)| C5 (𝛿) 
|C5 
(𝚫𝛿)| 
0.000 6.928756 0.000000 6.530705 0.000000 6.299530 0.000000 
0.017 6.928639 0.000117 6.528820 0.001885 6.297635 0.001895 
0.048 6.927464 0.001291 6.524584 0.006121 6.293916 0.005614 
0.077 6.925962 0.002793 6.520168 0.010537 6.290828 0.008702 
0.140 6.923800 0.004956 6.511990 0.018715 6.283493 0.016037 
0.193 6.921708 0.007048 6.505030 0.025676 6.277690 0.021840 
0.237 6.920490 0.008266 6.499470 0.031235 6.272898 0.026632 
0.308 6.917447 0.011309 6.490352 0.040354 6.265115 0.034415 
0.363 6.915768 0.012988 6.483770 0.046935 6.259614 0.039916 
0.406 6.914096 0.014660 6.478355 0.052351 6.254976 0.044554 
0.482 6.911069 0.017687 6.468905 0.061800 6.247288 0.052242 
0.531 6.909434 0.019321 6.463284 0.067421 6.242625 0.056905 
0.771 6.901348 0.027408 6.436263 0.094443 6.220235 0.079295 
All shifts in ppm      
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NaI to BN-Scaffold 2.48: Titration 2 
 
[NaI] Stock (M) [BN-scaffold] (M)    
0.771  0.00098     
[NaI] 
(M) C3 (𝛿) 
|C3 
(𝚫𝛿)| C7 (𝛿) 
|C7 
(𝚫𝛿)| C5 (𝛿) 
|C5 
(𝚫𝛿)| 
0.000 6.928788 0.000000 6.530669 0.000000 6.299615 0.000000 
0.017 6.928938 0.000149 6.528929 0.001740 6.298209 0.001406 
0.048 6.927013 0.001776 6.523737 0.006932 6.293749 0.005866 
0.077 6.926443 0.002346 6.520444 0.010225 6.290672 0.008943 
0.140 6.923809 0.004979 6.511702 0.018967 6.283169 0.016446 
0.193 6.921539 0.007250 6.504625 0.026043 6.277288 0.022327 
0.237 6.919967 0.008821 6.498878 0.031791 6.272471 0.027144 
0.309 6.917291 0.011498 6.489681 0.040988 6.264531 0.035084 
0.363 6.915142 0.013647 6.482632 0.048037 6.258696 0.040919 
0.406 6.913821 0.014968 6.477346 0.053322 6.254433 0.045182 
0.482 6.910806 0.017983 6.468244 0.062425 6.246842 0.052773 
0.532 6.909033 0.019756 6.461047 0.069621 6.240732 0.058883 
0.771 6.901437 0.027352 6.435029 0.095639 6.219413 0.080202 
All shifts in ppm      
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NaI to BN-Scaffold 2.48: Titration 3 
 
[NaI] Stock (M) [BN-scaffold] (M)    
0.777  0.00098     
[NaI] 
(M) C3 (𝛿) 
|C3 
(𝚫𝛿)| C7 (𝛿) 
|C7 
(𝚫𝛿)| C5 (𝛿) 
|C5 
(𝚫𝛿)| 
0.000 6.928667 0.000000 6.530696 0.000000 6.299555 0.000000 
0.041 6.927420 0.001247 6.525136 0.005560 6.294802 0.004753 
0.078 6.925657 0.003010 6.519908 0.010789 6.290386 0.009169 
0.141 6.923779 0.004888 6.511894 0.018803 6.283563 0.015992 
0.194 6.921792 0.006875 6.505005 0.025692 6.277680 0.021875 
0.239 6.920274 0.008393 6.499728 0.030969 6.273091 0.026464 
0.311 6.917724 0.010943 6.490563 0.040133 6.265375 0.034180 
0.366 6.915478 0.013189 6.483516 0.047180 6.259588 0.039967 
0.409 6.913946 0.014721 6.478370 0.052326 6.255248 0.044307 
0.486 6.911329 0.017338 6.469174 0.061522 6.247577 0.051978 
0.536 6.909035 0.019632 6.462515 0.068181 6.241998 0.057557 
0.777 6.902349 0.026318 6.436925 0.093771 6.220953 0.078602 
All shifts in ppm      
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2.6.6. Titration Fit Data 
 
CC-Scaffold 2.49 Data: Lithium Iodide 
π6-system   
Titration Ka (M-1) Error (%)  
1 0.05502084 5.44686547  
2 0.06391472 0.87493265  
3 0.06004288 0.84534222  
Average 0.05965948   





BN-Scaffold 2.48 Data: Lithium Iodide 
π6-system   
Titration Ka (M-1) Error (%)  
1 0.05143333 0.14510105  
2 0.05667633 0.21559881  
3 0.05673581 0.2334196  
Average 0.05494849   











CC-Scaffold 2.49 Data: Sodium Iodide 
π6-system   
Titration Ka (M-1) Error (%)  
1 0.26928284 1.15561696  
2 0.22408539 0.56017266  
3 0.18666979 0.22168182  
Average 0.22667934   





BN-Scaffold 2.48 Data: Sodium Iodide 
π6-system   
Titration Ka (M-1) Error (%)  
1 0.18584887 0.22566179  
2 0.20604828 0.67987845  
3 0.20170994 0.56146666  
Average 0.19786903   




2.6.7. NMR Spectra 
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Neutral, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6        0.000000    0.711232    0.000000 
      2          6        0.490090   -0.612318    0.000000 
      3          6       -0.425045   -1.671507    0.000000 
      4          6       -1.775002   -1.391529    0.000000 
      5          6       -2.240249   -0.066457    0.000000 
      6          6       -1.363946    0.998836    0.000000 
      7          6        2.240895    0.795595    0.000000 
      8          6        1.922227   -0.526167    0.000000 
      9          1       -0.075004   -2.697298    0.000000 
     10          1       -2.492461   -2.203204    0.000000 
     11          1       -3.307158    0.121632    0.000000 
     12          1       -1.725094    2.020807    0.000000 
     13          1        1.052471    2.553920    0.000000 
     14          1        3.207667    1.273508    0.000000 
     15          1        2.622146   -1.346159    0.000000 
     16          7        1.089088    1.550098    0.000000 
 --------------------------------------------------------- 
SCF Energy of neutral:    -363.7026772610000       au 
 Dipole moment (Debye): 
    x=  -0.876   y=   1.993   z=   0.000   Norm=   2.177 
  
HOMO =    -7.052 eV   LUMO =     0.885 eV   gap(HOMO-LUMO) =     7.937 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 36)   0.11318    3.0798 
  LUMO+3  ( 35)   0.10061    2.7377 
  LUMO+2  ( 34)   0.07899    2.1494 
  LUMO+1  ( 33)   0.07229    1.9671 
  LUMO    ( 32)   0.03252    0.8849 
  HOMO    ( 31)  -0.25916   -7.0521 
  HOMO-1  ( 30)  -0.27574   -7.5033 
  HOMO-2  ( 29)  -0.34030   -9.2600 
  HOMO-3  ( 28)  -0.39785  -10.8260 
  HOMO-4  ( 27)  -0.40347  -10.9790 
  HOMO-5  ( 26)  -0.41931  -11.4100 
  HOMO-6  ( 25)  -0.45685  -12.4315 
  HOMO-7  ( 24)  -0.47925  -13.0411 
  HOMO-8  ( 23)  -0.49597  -13.4960 
  HOMO-9  ( 22)  -0.49679  -13.5183 
 HOMO-10  ( 21)  -0.50561  -13.7583 
 HOMO-11  ( 20)  -0.54120  -14.7268 
Gap (au ; eV ; nm)   0.29168 ;    7.9370 ;    156.21 
 
Zero-point correction=                         0.130909 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=         -363.571768 au 
 





Electrostatic potential map (from -13.81 (red) to +27.61 (bleu) 
kcal/mol) plotted on the 0.005 electron.bohr-3 isodensity surface. 
  
 
Electrostatic potential map (from –12.55 (red) to +12.55 (bleu) 




The number of surface minima:     8 
   #       a.u.         eV      kcal/mol           X/Y/Z coordinate(Angstrom) 
     1 -0.03518150   -0.957337  -22.076743      -2.066262  -0.128122  -1.611475 
     2 -0.03518728   -0.957495  -22.080373      -2.087543  -0.139297   1.610904 
     3 -0.01561487   -0.424902   -9.798488      -1.115165   1.378661  -1.534010 
     4 -0.01562173   -0.425089   -9.802791      -1.133959   1.368612   1.532804 
     5 -0.03657775   -0.995331  -22.952907       1.107148  -1.320415   1.561307 
     6 -0.03659599   -0.995828  -22.964349       1.166566  -1.331020  -1.565691 
     7 -0.03356317   -0.913300  -21.061224       1.723934   0.258029  -1.563103 
     8 -0.03357063   -0.913503  -21.065907       1.658292   0.263506   1.555075 
 




















































Neutral, ground state, CAM-B3LYP/6-311G(d,p) 
 -------------------------------------------------------- 
 Center     Atomic            Coordinates (Angstroms) 
 Number     Number           X           Y           Z 
 -------------------------------------------------------- 
      1          6       -1.334244    0.978266    0.000000 
      2          6       -2.227904   -0.044215    0.000000 
      3          6       -1.798200   -1.406225    0.000000 
      4          6       -0.481910   -1.769279    0.000000 
      5          6        2.217629    0.892290    0.000000 
      6          6        1.072028    1.604113    0.000000 
      7          1       -1.633845    2.019812    0.000000 
      8          1       -3.284938    0.185787    0.000000 
      9          1       -2.573381   -2.167456    0.000000 
     10          1       -0.236146   -2.825698    0.000000 
     11          1        2.679696   -1.148344    0.000000 
     12          1        3.226789    1.272740    0.000000 
     13          1        0.933045    2.672752    0.000000 
     14          7        1.943389   -0.466079    0.000000 
     15          5        0.520134   -0.648133    0.000000 
     16          7        0.000000    0.709132    0.000000 
 -------------------------------------------------------- 
SCF Energy of neutral:    -367.1610610100000       au 
 Dipole moment (Debye): 
    x=   1.332   y=   0.716   z=   0.000   Norm=   1.512 
  
HOMO =    -7.061 eV   LUMO =     0.742 eV   gap(HOMO-LUMO) =     7.803 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 36)   0.11263    3.0648 
  LUMO+3  ( 35)   0.09827    2.6741 
  LUMO+2  ( 34)   0.08759    2.3834 
  LUMO+1  ( 33)   0.08359    2.2746 
  LUMO    ( 32)   0.02725    0.7415 
  HOMO    ( 31)  -0.25950   -7.0614 
  HOMO-1  ( 30)  -0.26723   -7.2717 
  HOMO-2  ( 29)  -0.35577   -9.6810 
  HOMO-3  ( 28)  -0.38222  -10.4007 
  HOMO-4  ( 27)  -0.40873  -11.1221 
  HOMO-5  ( 26)  -0.42471  -11.5569 
  HOMO-6  ( 25)  -0.45668  -12.4269 
  HOMO-7  ( 24)  -0.47925  -13.0411 
  HOMO-8  ( 23)  -0.49473  -13.4623 
  HOMO-9  ( 22)  -0.49523  -13.4759 
 HOMO-10  ( 21)  -0.51047  -13.8906 
 HOMO-11  ( 20)  -0.53036  -14.4318 
Gap (au ; eV ; nm)   0.28675 ;    7.8029 ;    158.90 
 
Zero-point correction=                      0.129295 (Hartree/Particle) 
Sum of electronic and zero-point Energies=      -367.031766 au 
 





Electrostatic potential map (from -13.81 (red) to +27.61 (bleu) 
kcal/mol) plotted on the 0.005 electron.bohr-3 isodensity surface. 
  
 
Electrostatic potential map (from –12.55 (red) to +12.55 (bleu) 
kcal/mol) plotted on the 0.005 electron.bohr-3 isodensity surface. 
  
 
The number of surface minima:     10 
   #       a.u.         eV      kcal/mol           X/Y/Z coordinate(Angstrom) 
     1 -0.03244464   -0.882864  -20.359338      -1.901013   0.143695  -1.594575 
     2 -0.03245238   -0.883074  -20.364192      -1.891513   0.152396   1.593999 
     3 -0.04016062   -1.092826  -25.201189      -0.951047  -1.524881  -1.597660 
     4 -0.04014069   -1.092284  -25.188683      -0.936221  -1.513266   1.597074 
     5 -0.01938094   -0.527382  -12.161737      -0.082306   0.455646  -1.524086 
     6 -0.01939535   -0.527774  -12.170773      -0.086083   0.472151   1.524952 
     7 -0.03081800   -0.838601  -19.338606       1.641866   1.446796   1.608209 
     8 -0.03080133   -0.838147  -19.328141       1.665684   1.407303  -1.608720 
     9 -0.02870841   -0.781196  -18.014814       1.799702  -0.499986  -1.567872 
    10 -0.02869120   -0.780727  -18.004013       1.768537  -0.550404   1.566465 
 





















































3. Cation Li+ 
Cation, ground state, CAM-B3LYP/6-311G(d) 
SCF Energy of neutral:    -7.264261449600000       au 
 
HOMO =   -65.857 eV   LUMO =    -6.324 eV   gap(HOMO-LUMO) =    59.533 
eV 
  
  MO    (#)         au         eV 
LUMO+4  (  6)   -0.06765    -1.8409 
LUMO+3  (  5)   -0.15880    -4.3212 
LUMO+2  (  4)   -0.15880    -4.3212 
LUMO+1  (  3)   -0.15880    -4.3212 
LUMO    (  2)   -0.23242    -6.3245 
HOMO    (  1)   -2.42020   -65.8570 
4. Cation Na+ 
Cation, ground state, CAM-B3LYP/6-311G(d) 
SCF Energy of neutral:    -162.0643713740000       au 
 
HOMO =   -41.191 eV   LUMO =    -6.287 eV   gap(HOMO-LUMO) =    34.904 
eV 
  
  MO    (#)         au         eV 
LUMO+4  ( 10)   -0.06495    -1.7674 
LUMO+3  (  9)   -0.13293    -3.6172 
LUMO+2  (  8)   -0.13293    -3.6172 
LUMO+1  (  7)   -0.13293    -3.6172 
LUMO    (  6)   -0.23106    -6.2875 
HOMO    (  5)   -1.51374   -41.1910 
HOMO-1  (  4)   -1.51374   -41.1910 
HOMO-2  (  3)   -1.51374   -41.1910 
HOMO-3  (  2)   -2.57941   -70.1893 
HOMO-4  (  1)  -38.82095 -1056.3718 
5. Cation K+ 
Cation, ground state, CAM-B3LYP/6-311G(d) 
SCF Energy of neutral:    -599.7694236890000       au 
 
HOMO =   -28.418 eV   LUMO =    -5.134 eV   gap(HOMO-LUMO) =    23.284 
eV 
  
  MO    (#)         au         eV 
LUMO+4  ( 14)   -0.05987    -1.6291 
LUMO+3  ( 13)   -0.11632    -3.1652 
LUMO+2  ( 12)   -0.11632    -3.1652 
LUMO+1  ( 11)   -0.11632    -3.1652 
LUMO    ( 10)   -0.18867    -5.1340 
HOMO    (  9)   -1.04433   -28.4177 
HOMO-1  (  8)   -1.04433   -28.4177 
HOMO-2  (  7)   -1.04433   -28.4177 
HOMO-3  (  6)   -1.68873   -45.9527 
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HOMO-4  (  5)  -10.85365  -295.3429 
HOMO-5  (  4)  -10.85365  -295.3429 
HOMO-6  (  3)  -10.85365  -295.3429 
HOMO-7  (  2)  -13.50678  -367.5382 




Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6        0.307921   -0.680635   -0.062389 
      2          6        0.304920    0.746816   -0.058240 
      3          6       -0.926799    1.423339   -0.118133 
      4          6       -2.103741    0.688059   -0.168964 
      5          6       -2.080104   -0.722875   -0.149710 
      6          6       -0.880108   -1.421052   -0.088830 
      7          6        2.426148    0.032177   -0.017362 
      8          6        1.672590    1.164162   -0.019563 
      9          1       -0.955863    2.506025   -0.134369 
     10          1       -3.055383    1.200282   -0.228964 
     11          1       -3.012514   -1.271050   -0.189815 
     12          1       -0.870532   -2.504342   -0.084801 
     13          1        1.939746   -2.031280   -0.070010 
     14          1        3.499091   -0.078188   -0.009933 
     15          1        2.043544    2.175720   -0.020285 
     16          7        1.613903   -1.078317   -0.028818 









SCF Energy of neutral:    -371.0455579090000       au 
 Dipole moment (Debye): 
    x=  -1.279   y=  -1.384   z=   4.479   Norm=   4.859 
  
HOMO =   -11.835 eV   LUMO =    -4.188 eV   gap(HOMO-LUMO) =     7.647 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 37)  -0.08743   -2.3791 
  LUMO+3  ( 36)  -0.09173   -2.4961 
  LUMO+2  ( 35)  -0.11866   -3.2289 
  LUMO+1  ( 34)  -0.14788   -4.0240 
  LUMO    ( 33)  -0.15390   -4.1878 
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  HOMO    ( 32)  -0.43491  -11.8345 
  HOMO-1  ( 31)  -0.46706  -12.7093 
  HOMO-2  ( 30)  -0.52901  -14.3951 
Gap (au ; eV ; nm)   0.28101 ;    7.6467 ;    162.14 
 
Zero-point correction=                        0.134049 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=        -370.909818 au 
 
Counterpoise fragments’ energies: 
Indole  -363.703468307 au 
Li+   -7.26441810962 au 
Isolated fragments’ energies at complex geometry: 
Indole  -363.701934411 au 





Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6        0.177993   -0.669158   -0.084717 
      2          6        0.180179    0.742733   -0.080471 
      3          6       -1.048582    1.428923   -0.030936 
      4          6       -2.207140    0.692550   -0.002892 
      5          6       -2.183485   -0.717010   -0.013880 
      6          6       -1.001999   -1.420371   -0.047657 
      7          6        2.329134    0.036172   -0.203107 
      8          6        1.559376    1.163833   -0.152531 
      9          1       -1.074941    2.511234   -0.036479 
     10          1       -3.162953    1.199727    0.020717 
     11          1       -3.120663   -1.258601    0.000025 
     12          1       -0.988867   -2.502872   -0.066521 
     13          1        1.814569   -2.023724   -0.288158 
     14          1        3.397941   -0.073405   -0.304481 
     15          1        1.926161    2.177323   -0.203503 
     16          7        1.509795   -1.080657   -0.092047 









SCF Energy of neutral:    -371.0372673710000       au 
 Dipole moment (Debye): 
    x=   4.458   y=  -1.368   z=   4.578   Norm=   6.534 
  
HOMO =   -11.942 eV   LUMO =    -4.276 eV   gap(HOMO-LUMO) =     7.666 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 37)  -0.09216   -2.5078 
  LUMO+3  ( 36)  -0.09978   -2.7152 
  LUMO+2  ( 35)  -0.10507   -2.8591 
  LUMO+1  ( 34)  -0.14184   -3.8597 
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  LUMO    ( 33)  -0.15713   -4.2757 
  HOMO    ( 32)  -0.43885  -11.9417 
  HOMO-1  ( 31)  -0.45798  -12.4623 
  HOMO-2  ( 30)  -0.52813  -14.3711 
Gap (au ; eV ; nm)   0.28172 ;    7.6660 ;    161.73 
 
Zero-point correction=                        0.133732 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=        -370.901519 au 
 
Counterpoise fragments’ energies: 
Indole  -363.703079724 au 
Li+   -7.26441400449 au 
Isolated fragments’ energies at complex geometry: 
Indole  -363.701215986 au 





Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6        0.840229   -1.397821   -0.113840 
      2          6        2.051955   -0.756203   -0.167598 
      3          6        2.139364    0.671872   -0.170467 
      4          6        1.026588    1.478399   -0.083523 
      5          6       -2.440850   -0.038990   -0.019109 
      6          6       -1.633256   -1.119981   -0.009866 
      7          1        0.750872   -2.477666   -0.128804 
      8          1        2.952023   -1.351542   -0.236550 
      9          1        3.130216    1.109654   -0.227659 
     10          1        1.172726    2.552271   -0.075182 
     11          1       -2.158442    2.030582   -0.065137 
     12          1       -3.519508   -0.033258   -0.013545 
     13          1       -1.885926   -2.167071   -0.005600 
     14          7       -1.706480    1.131192   -0.039471 
     15          5       -0.323394    0.805641   -0.081230 
     16          7       -0.306788   -0.665544   -0.035180 









SCF Energy of neutral:    -374.4998996900000       au 
 Dipole moment (Debye): 
    x=   1.487   y=  -0.161   z=   4.490   Norm=   4.732 
  
HOMO =   -11.657 eV   LUMO =    -4.521 eV   gap(HOMO-LUMO) =     7.136 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 37)  -0.08731   -2.3758 
  LUMO+3  ( 36)  -0.09046   -2.4615 
  LUMO+2  ( 35)  -0.10247   -2.7884 
  LUMO+1  ( 34)  -0.14908   -4.0567 
  LUMO    ( 33)  -0.16615   -4.5212 
 165 
  HOMO    ( 32)  -0.42840  -11.6574 
  HOMO-1  ( 31)  -0.46040  -12.5281 
  HOMO-2  ( 30)  -0.54588  -14.8542 
Gap (au ; eV ; nm)   0.26225 ;    7.1362 ;    173.74 
 
Zero-point correction=                        0.132230 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=        -374.366043 au 
 
Counterpoise fragments’ energies: 
BN-indole  -367.161061882 au 
Li+   -7.26443319399 au 
Isolated fragments’ energies at complex geometry: 
BN-indole  -367.159606133 au 





Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6        0.972560   -1.406347   -0.025133 
      2          6        2.157978   -0.759109    0.002985 
      3          6        2.245468    0.671083   -0.005855 
      4          6        1.152158    1.486152   -0.056226 
      5          6       -2.338602   -0.050831   -0.206959 
      6          6       -1.511313   -1.124681   -0.147662 
      7          1        0.876269   -2.484231   -0.031727 
      8          1        3.066400   -1.345310    0.027378 
      9          1        3.240879    1.101336    0.022957 
     10          1        1.299045    2.559158   -0.068694 
     11          1       -2.022724    2.024134   -0.247109 
     12          1       -3.412570   -0.044716   -0.312327 
     13          1       -1.758255   -2.173447   -0.204266 
     14          7       -1.589859    1.123983   -0.102888 
     15          5       -0.173321    0.793466   -0.123510 
     16          7       -0.190863   -0.661523   -0.057462 









SCF Energy of neutral:    -374.4936479500000       au 
 Dipole moment (Debye): 
    x=  -4.828   y=  -0.026   z=   4.522   Norm=   6.615 
  
HOMO =   -11.847 eV   LUMO =    -4.322 eV   gap(HOMO-LUMO) =     7.525 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 37)  -0.08781   -2.3894 
  LUMO+3  ( 36)  -0.09696   -2.6384 
  LUMO+2  ( 35)  -0.10981   -2.9881 
  LUMO+1  ( 34)  -0.13825   -3.7620 
  LUMO    ( 33)  -0.15883   -4.3220 
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  HOMO    ( 32)  -0.43537  -11.8470 
  HOMO-1  ( 31)  -0.45485  -12.3771 
  HOMO-2  ( 30)  -0.52884  -14.3905 
Gap (au ; eV ; nm)   0.27654 ;    7.5250 ;    164.76 
 
Zero-point correction=                        0.132094 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=        -374.359631 au 
 
Counterpoise fragments’ energies: 
BN-indole  -367.160143381 au 
Li+   -7.26442813609 au 
Isolated fragments’ energies at complex geometry: 
BN-indole  -367.158387072 au 





Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6        0.477827   -0.705781   -0.199824 
      2          6        0.454913    0.712694   -0.309237 
      3          6       -0.763456    1.351097   -0.599719 
      4          6       -1.908778    0.585066   -0.752122 
      5          6       -1.867322   -0.818429   -0.618427 
      6          6       -0.679817   -1.478459   -0.340592 
      7          6        2.565813    0.056007    0.062558 
      8          6        1.801548    1.165140   -0.128419 
      9          1       -0.799225    2.425611   -0.735894 
     10          1       -2.844668    1.063710   -1.012698 
     11          1       -2.771964   -1.393670   -0.771153 
     12          1       -0.647899   -2.559806   -0.278169 
     13          1        2.119608   -2.015964    0.088866 
     14          1        3.630263   -0.027619    0.214726 
     15          1        2.157229    2.181672   -0.166996 
     16          7        1.776082   -1.070414    0.035739 









SCF Energy of neutral:    -525.8192367450000       au 
 Dipole moment (Debye): 
    x=   2.194   y=   0.765   z=   6.161   Norm=   6.585 
  
HOMO =   -11.318 eV   LUMO =    -4.488 eV   gap(HOMO-LUMO) =     6.830 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 41)  -0.09377   -2.5516 
  LUMO+3  ( 40)  -0.09594   -2.6107 
  LUMO+2  ( 39)  -0.10091   -2.7459 
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  LUMO+1  ( 38)  -0.13406   -3.6480 
  LUMO    ( 37)  -0.16493   -4.4880 
  HOMO    ( 36)  -0.41594  -11.3183 
  HOMO-1  ( 35)  -0.44282  -12.0497 
  HOMO-2  ( 34)  -0.50541  -13.7529 
  HOMO-3  ( 33)  -0.55549  -15.1157 
Gap (au ; eV ; nm)   0.25101 ;    6.8303 ;    181.52 
 
Zero-point correction=                        0.132506 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=        -525.684741 au 
 
Counterpoise fragments’ energies: 
Indole  -363.703547338 au 
Na+   -162.064803965 au 
Isolated fragments’ energies at complex geometry: 
Indole  -363.701990186 au 





Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6        0.022717   -0.792341   -0.182325 
      2          6        0.074988    0.575983   -0.535831 
      3          6       -1.113625    1.328067   -0.529477 
      4          6       -2.289978    0.701725   -0.182342 
      5          6       -2.317820   -0.661883    0.163315 
      6          6       -1.171286   -1.426789    0.172415 
      7          6        2.161264   -0.279918   -0.670186 
      8          6        1.454858    0.878078   -0.833904 
      9          1       -1.105965    2.372519   -0.817117 
     10          1       -3.216275    1.261714   -0.187554 
     11          1       -3.263717   -1.122221    0.418630 
     12          1       -1.201072   -2.480049    0.423260 
     13          1        1.566571   -2.257519   -0.197741 
     14          1        3.206573   -0.481159   -0.847161 
     15          1        1.852854    1.812540   -1.198294 
     16          7        1.315947   -1.281700   -0.242971 









SCF Energy of neutral:    -525.8136993920000       au 
 Dipole moment (Debye): 
    x=  -4.482   y=  -0.703   z=   6.150   Norm=   7.642 
  
HOMO =   -11.394 eV   LUMO =    -4.654 eV   gap(HOMO-LUMO) =     6.740 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 41)  -0.08598   -2.3396 
  LUMO+3  ( 40)  -0.09728   -2.6471 
  LUMO+2  ( 39)  -0.10318   -2.8077 
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  LUMO+1  ( 38)  -0.12394   -3.3726 
  LUMO    ( 37)  -0.17103   -4.6540 
  HOMO    ( 36)  -0.41872  -11.3940 
  HOMO-1  ( 35)  -0.43641  -11.8753 
  HOMO-2  ( 34)  -0.50458  -13.7303 
  HOMO-3  ( 33)  -0.54715  -14.8887 
Gap (au ; eV ; nm)   0.24769 ;    6.7400 ;    183.95 
 
Zero-point correction=                        0.132188 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=        -525.679593 au 
 
Counterpoise fragments’ energies: 
Indole  -363.703322209 au 
Na+   -162.064809043 au 
Isolated fragments’ energies at complex geometry: 
Indole  -363.701840922 au 





Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6        0.616447   -1.459392   -0.358981 
      2          6        1.815773   -0.862318   -0.635243 
      3          6        1.924762    0.557951   -0.772875 
      4          6        0.853552    1.403513   -0.602162 
      5          6       -2.593498   -0.007246    0.093320 
      6          6       -1.811235   -1.105944    0.065248 
      7          1        0.502114   -2.535162   -0.292660 
      8          1        2.681245   -1.487779   -0.807710 
      9          1        2.898112    0.957741   -1.040495 
     10          1        1.011252    2.466711   -0.744889 
     11          1       -2.280638    2.043072   -0.163305 
     12          1       -3.660120    0.030621    0.248561 
     13          1       -2.081640   -2.142754    0.177143 
     14          7       -1.844397    1.137482   -0.114753 
     15          5       -0.485539    0.765103   -0.329434 
     16          7       -0.494267   -0.692760   -0.177549 









SCF Energy of neutral:    -529.2751874739999       au 
 Dipole moment (Debye): 
    x=  -2.593   y=  -0.562   z=   6.001   Norm=   6.561 
  
HOMO =   -11.178 eV   LUMO =    -4.555 eV   gap(HOMO-LUMO) =     6.624 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 41)  -0.08104   -2.2052 
  LUMO+3  ( 40)  -0.09617   -2.6169 
  LUMO+2  ( 39)  -0.09665   -2.6300 
  LUMO+1  ( 38)  -0.14337   -3.9013 
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  LUMO    ( 37)  -0.16738   -4.5546 
  HOMO    ( 36)  -0.41080  -11.1784 
  HOMO-1  ( 35)  -0.43518  -11.8419 
  HOMO-2  ( 34)  -0.52349  -14.2449 
Gap (au ; eV ; nm)   0.24342 ;    6.6238 ;    187.18 
 
Zero-point correction=                        0.130827 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=        -529.142497 au 
Counterpoise fragments’ energies: 
BN-indole  -367.161431985 au 
Na+   -162.064836882 au 
Isolated fragments’ energies at complex geometry: 
BN-indole  -367.160034439 au 





Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6       -1.161736    1.410933    0.023739 
      2          6       -2.318143    0.716775    0.145684 
      3          6       -2.365219   -0.703079   -0.017439 
      4          6       -1.265718   -1.457217   -0.320224 
      5          6        2.123439    0.224706   -0.732802 
      6          6        1.290410    1.248444   -0.436021 
      7          1       -1.098372    2.486632    0.129621 
      8          1       -3.228439    1.258304    0.363253 
      9          1       -3.333124   -1.179435    0.099109 
     10          1       -1.387141   -2.526883   -0.443545 
     11          1        1.846436   -1.825693   -1.071838 
     12          1        3.173027    0.277323   -0.978058 
     13          1        1.502784    2.305103   -0.392424 
     14          7        1.424447   -0.983853   -0.711992 
     15          5        0.018428   -0.705064   -0.496699 
     16          7       -0.000797    0.729656   -0.256145 









SCF Energy of neutral:    -529.2701887130000       au 
 Dipole moment (Debye): 
    x=   5.204   y=  -0.838   z=   5.535   Norm=   7.643 
  
HOMO =   -11.443 eV   LUMO =    -4.674 eV   gap(HOMO-LUMO) =     6.769 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 41)  -0.08110   -2.2068 
  LUMO+3  ( 40)  -0.09800   -2.6667 
  LUMO+2  ( 39)  -0.10463   -2.8471 
  LUMO+1  ( 38)  -0.12489   -3.3984 
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  LUMO    ( 37)  -0.17176   -4.6738 
  HOMO    ( 36)  -0.42052  -11.4429 
  HOMO-1  ( 35)  -0.42975  -11.6941 
  HOMO-2  ( 34)  -0.51137  -13.9151 
  HOMO-3  ( 33)  -0.52964  -14.4122 
Gap (au ; eV ; nm)   0.24876 ;    6.7691 ;    183.16 
 
Zero-point correction=                        0.130676 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=        -529.137485 au 
 
Counterpoise fragments’ energies: 
BN-indole  -367.160562630 au 
Na+   -162.064858223 au 
Isolated fragments’ energies at complex geometry: 
BN-indole  -367.159022309 au 





Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6       -0.728894    0.538380    0.573102 
      2          6       -0.676321    0.197607   -0.804123 
      3          6        0.460980    0.552095   -1.546996 
      4          6        1.505427    1.201170   -0.912326 
      5          6        1.440515    1.512423    0.459763 
      6          6        0.327694    1.187823    1.217072 
      7          6       -2.658985   -0.453441    0.019386 
      8          6       -1.919422   -0.440656   -1.122606 
      9          1        0.505264    0.348539   -2.610695 
     10          1        2.371637    1.511759   -1.483760 
     11          1        2.259328    2.050118    0.921757 
     12          1        0.265817    1.467303    2.262324 
     13          1       -2.308993    0.301090    1.968534 
     14          1       -3.657783   -0.823611    0.188380 
     15          1       -2.233951   -0.809954   -2.085076 
     16          7       -1.944750    0.118301    1.047568 









SCF Energy of neutral:    -963.5099480540000       au 
 Dipole moment (Debye): 
    x=   3.691   y=   5.832   z=  -2.758   Norm=   7.433 
  
HOMO =   -10.996 eV   LUMO =    -3.953 eV   gap(HOMO-LUMO) =     7.043 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 45)  -0.08548   -2.3260 
  LUMO+3  ( 44)  -0.09168   -2.4947 
  LUMO+2  ( 43)  -0.09554   -2.5998 
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  LUMO+1  ( 42)  -0.12093   -3.2907 
  LUMO    ( 41)  -0.14527   -3.9530 
  HOMO    ( 40)  -0.40410  -10.9961 
  HOMO-1  ( 39)  -0.42858  -11.6623 
  HOMO-2  ( 38)  -0.49132  -13.3695 
  HOMO-3  ( 37)  -0.54267  -14.7668 
Gap (au ; eV ; nm)   0.25883 ;    7.0431 ;    176.04 
 
Zero-point correction=                        0.132191 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=        -963.376498 au 
 
Counterpoise fragments’ energies: 
Indole  -363.703289471 au 
K+   -599.769520006 au 
Isolated fragments’ energies at complex geometry: 
Indole  -363.702126998 au 





Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 





Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 --------------------------------------------------------- 
 Center     Atomic             Coordinates (Angstroms) 
 Number     Number            X           Y           Z 
 --------------------------------------------------------- 
      1          6        0.314823    0.973659   -1.335211 
      2          6        1.427311    1.406006   -0.672477 
      3          6        1.520744    1.329583    0.752374 
      4          6        0.524891    0.800410    1.533396 
      5          6       -2.683477   -0.440807   -0.056015 
      6          6       -1.944727   -0.050177   -1.115129 
      7          1        0.201973    1.063510   -2.409545 
      8          1        2.224645    1.867332   -1.239772 
      9          1        2.417085    1.734853    1.212233 
     10          1        0.658995    0.803272    2.609479 
     11          1       -2.412671   -0.443846    2.016467 
     12          1       -3.683730   -0.843888   -0.069846 
     13          1       -2.198436   -0.046201   -2.162281 
     14          7       -1.986686   -0.251986    1.125442 
     15          5       -0.720338    0.335339    0.824579 
     16          7       -0.716715    0.425103   -0.635019 









SCF Energy of neutral:    -966.9661946990000       au 
 Dipole moment (Debye): 
    x=  -3.864   y=   6.233   z=  -0.607   Norm=   7.359 
  
HOMO =   -10.908 eV   LUMO =    -3.999 eV   gap(HOMO-LUMO) =     6.910 
eV 
  
  MO      (#)      au        eV 
  LUMO+4  ( 45)  -0.07930   -2.1579 
  LUMO+3  ( 44)  -0.09244   -2.5154 
  LUMO+2  ( 43)  -0.09433   -2.5669 
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  LUMO+1  ( 42)  -0.12867   -3.5013 
  LUMO    ( 41)  -0.14695   -3.9987 
  HOMO    ( 40)  -0.40087  -10.9082 
  HOMO-1  ( 39)  -0.42060  -11.4451 
  HOMO-2  ( 38)  -0.50801  -13.8237 
  HOMO-3  ( 37)  -0.52826  -14.3747 
Gap (au ; eV ; nm)   0.25392 ;    6.9095 ;    179.44 
 
Zero-point correction=                        0.130549 
(Hartree/Particle) 
Sum of electronic and zero-point Energies=        -966.834457 AU 
 
Counterpoise fragments’ energies: 
BN-indole  -367.161373848 au 
K+   -599.769533975 au 
Isolated fragments’ energies at complex geometry: 
BN-indole  -367.160295120 au 




Cation, ground state, CAM-B3LYP/6-311G(d,p) 
 




18. Binding energy calculations 
 
According to: 
Kirschner, Karl N., Jennifer B. Sorensen, et J. Phillip Bowen. « Calculating Interaction 
Energies Using First Principle Theories: Consideration of Basis Set Superposition Error 
and Fragment Relaxation ». Journal of Chemical Education 84, no 7 (juillet 2007): 1225. 
https://doi.org/10.1021/ed084p1225. 
 
∆ERig corresponds to the binding energy taking into account the basis set superposition 
error (BSSE). 
 
Calculation method: CAM-B3LYP/6-311G(d,p) 
 ∆E (kcal/mol) 
A...B ∆E(AB) ∆ESP(AB) ∆EfCP(AB) ∆ERig(AB) ∆EBSSE(A) ∆EBSSE (B) ∆EBSSE(AB) ∆ERel(A) ∆ERel(B) ∆ERel(AB) 
Indole-π6...Li+ -49.334 -49.800 -48.740 -48.273 0.963 0.098 1.061 0.466 0.000 0.466 
BN-indole-π6...Li+ -46.798 -47.711 -46.690 -45.777 0.913 0.108 1.021 0.913 0.000 0.913 
Indole-π5...Li+ -44.132 -45.049 -43.784 -42.867 1.170 0.096 1.265 0.917 0.000 0.917 
BN-indole-π5...Li+ -42.875 -44.553 -43.346 -41.668 1.102 0.105 1.207 1.678 0.000 1.678 
Indole-π6…Na+ -32.749 -33.180 -31.931 -31.500 0.977 0.271 1.249 0.431 0.000 0.431 
BN-indole-π6…Na++ -31.222 -31.866 -30.697 -30.053 0.877 0.292 1.169 0.644 0.000 0.644 
Indole-π5…Na+ -29.274 -29.799 -28.594 -28.070 0.930 0.275 1.204 0.525 0.000 0.525 
BN-indole-π5…Na+ -28.085 -29.364 -28.092 -26.813 0.967 0.306 1.272 1.279 0.000 1.279 
Indole-π6..K+ -23.749 -24.095 -23.305 -22.959 0.729 0.060 0.790 0.345 0.000 0.345 
BN-indole-π6..K+ -22.408 -22.889 -22.143 -21.662 0.677 0.069 0.746 0.481 0.000 0.481 
Indole-π5…K+ — — — — — — — — — — 
BN-indole-π5…K+ — — — — — — — — — — 
 
 
